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ABSTRACT: Graphene and its derivatives are heralded as
“miracle” materials with manifold applications in diﬀerent
sectors of society from electronics to energy storage to
medicine. The increasing exploitation of graphene-based
materials (GBMs) necessitates a comprehensive evaluation
of the potential impact of these materials on human health
and the environment. Here, we discuss synthesis and
characterization of GBMs as well as human and environ-
mental hazard assessment of GBMs using in vitro and in
vivo model systems with the aim to understand the
properties that underlie the biological eﬀects of these
materials; not all GBMs are alike, and it is essential that we disentangle the structure−activity relationships for this class
of materials.
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Graphene is ﬁrst-in-classthe ﬁrst two-dimensional(2D) atomic crystal.1 The many extraordinary proper-ties of this material, such as mechanical stiﬀness,
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strength, and elasticity as well as the high electrical and thermal
conductivity, have generated considerable excitement since the
initial discovery, and graphene and its derivaties are currently
being explored for a multitude of diﬀerent applications.2 Safe
and sustainable development of graphene-enabled technologies
and products requires close attention to the potential impact
of these materials on human health and the environment.3
Indeed, safety assessment is an integral part of the innovation
process.4
Material characterization, in turn, is a key element of hazard
assessment. The toxicological evaluation of carbon nanotubes is
a case in point. Ten years ago, carbon nanotubes were suggested
to display “asbestos-like” pathogenicity in an animal model in
the sense that long and rigid, but not short or tangled, carbon
nanotubes elicited granuloma formation and inﬂammation
following intraperitoneal injection in mice.5 We now understand
that carbon nanotubes adhere to a certain extent to the so-called
pathogenic ﬁber paradigm, and that some types of multiwalled
carbon nanotubes may be considered as potentially carcinogenic
to humans.6 However, other members of the same family of
materials have been found to be nontoxic7,8 and may even
undergo degradation,9 suggesting that not all carbon nanotubes
are asbestos-like (reviewed in ref 10). In fact, carbon nanotubes,
if appropriately puriﬁed and surface-modiﬁed, hold promising
prospects in nanomedicine, for instance, for drug or gene
delivery and/or imaging.10
Thus, while it is evident that important lessons can be learned
from previous studies of other engineered nanomaterials, it is
equally important to avoid extrapolation from the study of one
class of nanomaterials to anotherif we acknowledge that new
materials have new and useful properties, then we must also
accept that such new materials could pose new or unanticipated
risks.11 This is not to say that the biological or toxicological eﬀects
of a novel material are necessarily “novel”. Indeed, the ﬁnal com-
mon pathways of cellular or organ damage (e.g., oxidative stress,
inﬂammation, carcinogenesis) may be conserved for diﬀerent
(nano)materials,12 but it is nevertheless of considerable impor-
tance to understand how those pathways are triggered: in
essence, toxicology seeks to understand the structure−activity
relationship of a chemical or a material. We need to understand
the properties of the materials and how these are connected to
the biological eﬀects in order to make them both useful and
safe.13,14
The Graphene Flagship Project (www.graphene-ﬂagship.eu)
is, along with the Human Brain Project, the ﬁrst of the European
Commission’s Future and Emerging Technology (FET)
Flagship Projects, whose mission is to address major scientiﬁc
and technological challenges through long-term, multidiscipli-
nary research and development eﬀorts. The Graphene Flagship
was launched in 2013 and is expected to run for 10 years; the
consortium consists of over 150 academic and industrial
research groups in more than 20 countries. Safety assessment
is an essential requirement that cannot be dissociated from the
development of new technologies. Therefore, the Graphene
Flagship has invested considerable eﬀorts in evaluating the poten-
tial impact of graphene-basedmaterials (GBMs) on human health
and the environment.2 The aim of the present review is to provide
a comprehensive view of human and environmental hazard
assessment of GBMs, taking as a starting point the work that has
been conducted during the ﬁrst half of the Graphene Flagship,
along with other relevant literature. We address the main
exposure routes for GBMs and the key target organs including
the immune system, the skin, the lungs, the cardiovascular
system, the gastrointestinal system, the central nervous system,
and the reproductive system, as well as a wide range of organisms
including bacteria, algae, plants, invertebrates, and vertebrates in
a variety of ecosystems. We also address the synthesis and
characterization of GBMs as a thorough understanding of the
material itself is crucial in any (nano)toxicological evalua-
tion.15,16 We brieﬂy discuss exposure and life cycle analysis of
GBMs though the information is relatively sparse at this point.4
Overall, with this survey of recent research on the safety
assessment of GBMs, we intend to emphasize the importance of
knowing the material as “graphene” is not a single material but a
class of materials, and it stands to reason that the biological
eﬀects of these materials may vary as a function of their intrinsic
properties.17 Moreover, it is important to know the test system,
as diﬀerent tests may address diﬀerent questions, but only within
the applicability domain of the test.18 To understand the
biological impact of GBMs, systematic studies using multiple
test systems spanning from in vitro to in vivomodels are required.
Furthermore, close attention both to human health and the
environment19,20 is needed in order to maximize the societal
beneﬁts of these novel materials.
SYNTHESIS AND CHARACTERIZATION OF
GRAPHENE-BASED MATERIALS
One important concern in graphene research is that the term
“graphene” is used in a generic manner to describe many
diﬀerent GBMs.17,21 In an attempt to remedy this situation, the
Graphene Flagship proposed a classiﬁcation scheme for GBMs
that takes into account three key parameters: the number of
graphene layers, the average lateral size, and the carbon-to-
oxygen (C/O) atomic ratio.22 The use of such a classiﬁcation
framework (Figure 1) (and see also Supporting Information)
may facilitate the comparison between studies performed in
diﬀerent laboratories and may also enable the assignment of
speciﬁc physicochemical properties with the safety proﬁle of
GBMs.
Synthesis of Graphene-Based Materials. There are
numerous reports in the literature regarding diﬀerent synthetic
methodologies,23−25 but certain requirements need to be
fulﬁlled when graphene materials are produced for biological
applications including their toxicological evaluation.17
In general, for in vitro studies, the materials must be provided
as stable aqueous solutions, and the amount of impurities should
be carefully controlled. In addition to chemical contaminants
arising from the synthesis, biological contaminants, i.e., microbes
or parts of microbes (endotoxin), need to be considered, as
production is often not performed under aseptic conditions or
using sterile solvents.26 Some general approaches to obtain
GBMs for biological applications are summarized below.
Graphene.Graphene dispersions can be produced via exfolia-
tion of graphite using ultrasonication.27 For successful exfolia-
tion in water, the assisted intercalation of small molecules or
solvents between the layers is commonly used. For instance,
insertion of chlorin-e6 (Ce6) showed a successful exfoliation of
graphite in biocompatible media (water or phosphate buﬀer).28
Plant extracts have also been used for the exfoliation of graphite
in water by sonication.29 Furthermore, the liquid phase exfolia-
tion of graphite in diﬀerent animal sera conducted to low toxicity
graphene suspension using a regular kitchen blender.30 Using a
diﬀerent approach, Liu et al. devised an eﬀective method to
produce high-quality multilayer graphene in large amounts by
the exfoliation of graphite under microwave irradiation through
the intercalation of ammonium persulfate or hydrogen peroxide.31
The irradiation causes the decomposition of the oxidizing agents
into gaseous oxygen, which gives rise to the exfoliation. Stable
water dispersions of graphene can also be prepared by ball-milling
treatments. In particular, the exfoliation of graphite through
interactions with melamine allows the production of the material
with low amount of defects.32 Excess melamine can subsequently
be removed by dialysis. Moreover, after lyophilization of these
aqueous graphene suspensions, a soft powder of few-layer
(FLG) graphene is obtained, which can be easily dispersed in
aqueous media. The process, developed in the Graphene Flag-
ship, thus comprises four steps: (i) the mechanochemical inter-
calation of organic molecules (melamine) into graphite, fol-
lowed by suspension in water; (ii) the washing of suspended
graphene to eliminatemost of themelamine; (iii) the isolation of
stable graphene sheets; and (iv) freeze-drying to obtain
graphene powder.33 Furthermore, a recent approach for scalable
and environmentally friendly production of graphene via liquid
phase exfoliation involved a wet ball-milling process in the
presence of liquid nitrogen and several alcohols.34
Graphene Oxide (GO). Most of the methods proposed to
synthesize GO are based on oxidation of graphite following a
modiﬁed Hummers’ protocol, which involves the use of oxidizing
reagents and acids.However, thismethod yieldsGOwith diﬀerent
degrees of oxidation and impurities. Additional puriﬁcation steps
are necessary to enhance the purity of the material.35 It has been
reported that the starting graphitic materials play an important
role not only in terms of general yields but also for the structural
properties of the resulting GO sheets.36 Coleman et al. have
recently prepared GO sheets with diﬀerent sizes by sonication in
aqueous dispersions and explored the relationship between the
total sonication energy and the average size of the GO sheets.37
In order to avoid some of the pitfalls encountered with com-
mercial preparations, GO suspensions were produced speciﬁcally
in the Graphene Flagship from graphite ﬂakes. These water-based
suspensions were produced following a modiﬁed Hummers’
method,35 further improved to ensure endotoxin-free suspensions
of single- to few-layer GO sheets of high chemical purity.26,36
Thesematerials now exist in a range of diﬀerent lateral dimensions
or thicknesses38,39 in order to assess the role of these physico-
chemical characteristics with respect to biological impact.40,41
Furthermore, a suite of characterization techniques has been
established in order to conﬁrm the quality, reproducibility, and
low batch-to-batch variability of each synthesis.42
Reduced Graphene Oxide (rGO). Typical methods to obtain
rGO include the chemical, thermal, and electro/photochemical
reduction of GO. Chemical reduction prevails over nonchemical
reduction approaches because of the improved quality,
eﬃciency, and the fact that stable dispersions of rGO can be
obtained. The most eﬀective chemical reductant is hydrazine;
however, this reagent is not very popular because of its toxicity to
humans and the environment. During the past decade, hydrazine
and other toxic chemicals have been replaced by more bio-
compatible and environmentally friendly reductants, known as
“green” reducing agents.43 Some examples include vitamin C,44
starch-based materials,29 sugars,45 plant extracts,46 or micro-
organisms.47 Nevertheless, even these reductants have short-
comings related to puriﬁcation processes and the diﬃculty of
large-scale production.48 In a recent study, GO was reduced to
rGO by ultrasonic irradiation at 50 °C in the absence of a
reducing agent.49 It is often shown that a simple heat treatment
is enough to perform the reduction of GO even in air.50 This is
attractive because it is fast, and one avoids contamination of the
material with exogenous elements (such as nitrogen when hydra-
zine is used). When heating is performed in a protective atmos-
phere (vacuum, inert gas), a rather high C/O ratio is obtained.51
Although most of the synthetic methodologies discussed
above yield high-quality graphene, the impossibility of scaling
these methods limits their industrial applications. Therefore,
obtaining a large amount of biocompatible graphene in a simple
and low-cost manner remains a considerable challenge.Methods
Figure 1. Classiﬁcation framework for graphene-based materials. Reprinted with permission from ref 22. Copyright 2014 Wiley-VCH Verlag
GmbH & Co, KGaA, Weinheim.
such as the liquid phase exfoliation of graphite,52,53 including
“green” reducing reagents (e.g., honey),54 or exfoliating agents
(e.g., sucrose, glucose, or silk proteins),55−57 and techniques
such as microwave58 or ball-milling59,60 are the most recent
approaches employed to increase the concentration of graphene
dispersions in an economically feasible and environmentally
friendly way. Recently, some companies have developed the
electrochemical exfoliation of graphite.61 This method has great
potential; however, the quality of graphene is still low as defects
are generated during the process.61 GO can be more easily
produced, and companies are already able to produce hundreds
of kilograms of GO.
Characterization of Graphene-Based Materials. For
proper hazard assessment, the materials need to be well-char-
acterized using standardized and validated characterization
techniques.62 Given the variety of available GBMs, a description
of the physicochemical properties must be provided in all
toxicological and pharmacological studies.63 For chemical char-
acterization, the most commonly used techniques are X-ray
photoelectron spectroscopy (XPS), Fourier transform infrared
(FTIR) spectroscopy, Raman spectroscopy, X-ray diﬀraction
(XRD), thermogravimetric analysis (TGA), and elemental ana-
lysis. Transmission electron microscopy (TEM), scanning elec-
tron microscopy (SEM), and atomic force microscopy (AFM)
provide information on the morphology and dimensions of the
material (Table 1). The limulus amoebocyte lysate (LAL) assay
is commonly used to check for endotoxin content of nano- and
biomaterials, but recent studies have shown that GBMs cause
interferences with the assay, and an alternative macrophage-
based assay was proposed.26 Endotoxin contamination may
mask or lead to the misinterpretation of the biological eﬀects of
biomaterials and precludes their medical use.64
It is important to note that even when using a synthetic
methodology that selectively leads to a certain graphenematerial
(e.g., GO) the ﬁnal product is often not homogeneous, but a
broad distribution of components with diﬀerent properties.
Hence, whereas apparently contradictory results have appeared
in the literature, for example, in terms of bioaccumulation in
diﬀerent organs (discussed below), it is important to point out
that these disparities may be due to the existence of diﬀerent
graphene morphologies as well as the use of diﬀerent biological
model systems. In general, the toxicity (or safety) of GBMs
depends on physicochemical properties such as size, number of
layers, and surface chemistry22 (supporting text and Figure S1).
Moreover, the presence of impurities and the graphene synthetic
methodology used may also inﬂuence the toxicological
responses.65 The lateral dimension of the material is one
important parameter, as we shall discuss below. The number of
graphene layers is also important as this will determine speciﬁc
surface area, absorptive capacity, and bending stiﬀness. As the
surface area is inversely proportional to the number of layers, it is
expected that the adsorptive capacity for biological molecules
(biocorona formation)10 increases as this number decreases.
GBMs may possess a wide variety of chemical surfaces. Hence,
the surface of pristine graphene is hydrophobic, and the surface
of GO with extensive oxygenated functions like carboxyl, epoxy,
and hydroxyl groups is highly hydrophilic, whereas rGO pre-
sents intermediate characteristics. The diﬀerent degree of oxida-
tion (C/O ratio) may determine the interactions with proteins
and other biomolecules.66 Furthermore, functionalization with
poly(ethylene glycol) (PEG), poly(vinyl alcohol), chitosan, or
pluronic modulates the biocompatibility of GBMs.67−69
Functionalization can aﬀect the surface charge of the material,
which may impact cellular internalization and other biological
interactions. In conclusion, the way in whichGBMs are prepared
is of key importance for the potential impact on biological sys-
tems. Furthermore, for speciﬁc applications, quality and adher-
ence to regulatory standards will be critical. For such applica-
tions, heterogeneity in the produced materials (batch-to-batch
variability for a single producer or variability between diﬀerent
producers) and lack of international and regulatory standards
are important issues, perhaps not for their initial translation to
the market but for a wider acceptance and penetration of the
market. Moreover, in the context of clinical translation of GBMs,
one of the issues that one will have to overcome is the current
medium-to-high variability observed between diﬀerent synthesis
batches. Production methods will have to progress toward better
GMP (good manufacturing practices) compliance (e.g., narrow
polydispersity, homogeneous functionalization) to allow for
approval and registration of GBMs.
Dissecting the Role of Material Properties: Reference
Libraries. To dissect the role of (nano)material properties on
the biological impact, access to appropriate reference material
libraries should be considered. In 2009, Nel and co-workers
proposed the creation of a standard nanomaterial library includ-
ing the principal classes of nanomaterials and nanoparticles.70
The authors stated “it is important to link the library develop-
ment to a nanomaterial classiﬁcation that allows toxicological
mechanisms to be interpreted in terms of intrinsic material
properties”. Since then, some examples of such material libraries
have emerged. Hence, a custom-designed material library for
testing the toxicity of metal oxides was developed taking into
account well-established methods available to produce and
characterize such nanoparticles.71 Walkey et al.72 characterized
the serum protein corona “ﬁngerprint” formed on a library of
105 surface-modiﬁed gold nanoparticles, thereby providing a
rich source of information with which to develop quantitative
relationships to predict the biological responses to such
Table 1. Characterization of Graphene-Based Materials
property technique
lateral dimensions electron microscopy (TEM, SEM)
atomic force microscopy (AFM)
dynamic light scattering (DLS)
number of layers electron microscopy (TEM)
atomic force microscopy (AFM)
Raman spectroscopy
surface charge ζ-potential
C/O atomic ratio X-ray photoelectron spectroscopy (XPS)
elemental analysis
chemical structure/
functionalization
X-ray photoelectron spectroscopy (XPS)
elemental analysis
Raman spectroscopy
thermogravimetric analysis (TGA)
ζ-potential
Fourier transform infrared spectroscopy
(FTIR)
metal impurities X-ray electron diﬀraction (XRD)
total reﬂection X-ray ﬂuorescence (TXRF)
atomic adsorption spectroscopy
inductively coupled plasma-mass spectrometry
(ICP-MS)
endotoxin content limulus amoebocyte lysate (LAL) assay
macrophage-based TNF expression test
(TET)
nanoparticles. Zhou et al.,73 in turn, developed a combinatorial
library of 80 functionalized carbon nanotubes to reveal
structure−activity relationships with respect to cytotoxicity
and immune responses. A systematic methodology relying on
the combination of computational methods and the properties
of nanomaterials to generate libraries that permit rapid screening
of cells and biologically relevant organisms has been recently
proposed.74 The authors oﬀered examples of libraries that can be
constituted of nanomaterials and nanoparticles characterized by
their chemical composition. Graphene was included in the family
of nanocarbons along with carbon nanotubes and fullerenes.
However, we believe that the chemical composition is not the only
parameter that one should consider as the chemical structure of
graphene diﬀers remarkably from that of nanotubes and fullerenes.
Furthermore, graphene constitutes a whole class of materials with
diﬀerent characteristics and, therefore, likely also diﬀerent
biological eﬀects.22 Our recent attempts to classify GBMs
according to certain well-deﬁned parameters21,22 are important
ﬁrst steps toward the development of a reference library includ-
ing graphene and its derivatives, enabling a detailed dissection of
structure−activity relationships to assess biological eﬀects. It is
noted that GBMs have not yet been included, for instance, in the
nanomaterial repository of the European Commission’s Joint
Research Centre (JRC), and this is likely related to the fact that
the International Organisation for Standardisation (ISO) is still
deliberating on the deﬁnition and material speciﬁcations of
graphene and related materials. The inclusion of graphene as a
representative industrial nanomaterial in the aforementioned
repository and the creation of a speciﬁc reference library of well-
characterized GBMs will be fundamental for benchmarking
purposes in basic and regulatory research.However, in thismoment,
we need to rely mainly on the physicochemical characteristics of
individual GBMs that are reported in the literature.
BIODISTRIBUTION AND FATE OF GRAPHENE-BASED
MATERIALS
The fate of GBMs in the body of an exposed organism is
governed both by their intrinsic physicochemical characteristics
such as lateral dimensions, thickness, and C/O ratio/
functionalization and by their extrinsic or acquired features
upon contact with the biological environment, largely dictated
by the biocorona.10 In addition, the portal of entry into the body
is also a major determinant of the subsequent fate of the
materials. The intrinsic characteristics of GBMs are expected to
inﬂuence their biodistribution, translocation to secondary
organs, accumulation, degradation, and clearance. However,
these characteristics may be altered by the adsorption of proteins
and other biomolecules present in the biological milieu.75
In addition, the local ion concentrationmay aﬀect nanomaterials
including GBMs.76 These interactions can modify the GBMs in
such a way that the initial shape, surface charge, thickness (in turn
aﬀecting the hydrodynamic diameter), or colloidal stability is
altered, which may impact biological behavior of the material.77
Notably, these acquired features may change dynamically over
time and evolve as a function of the local environment as GBMs
move from one biological compartment to another (for instance,
from the lungs to the bloodstream). However, the intrinsic
material properties are also subject to change, as a result of
degradation by immune cells (discussed below) or other forms
of biotransformation,78 thus underscoring the importance of
characterizing the material not only in its pristine form but also
in situ (in the test system during or after exposure) to the extent
that this is possible. With this in mind, we discuss studies on the
biodistribution and fate of GBMs upon various routes of
administration relevant either for occupational or environmental
exposures or routes that are relevant for biomedical applications
of GBMs.
Multiple Routes of Exposure to Graphene-Based
Materials. To investigate the impact of oral administration,
Zhang et al. labeled small and large (both nanosized) rGO sheets
with 125I to assess their biodistribution over 60 days after oral
gavage.79 Both materials were found in blood, heart, lungs, liver,
and kidneys, with a signiﬁcantly higher amount in kidneys when
compared to the control at day 1, decreasing rapidly, but still
remaining above control by days 15 and 60. These results suggest
that both materials were quickly absorbed in the gastrointestinal
tract and reached secondary organs via the systemic circulation.
In contrast, diﬀerent outcomes were reported in a study on
PEGylated GBMs.80 In the latter case, the in vivo biodistribution
after oral gavage of PEGylated, nanosized GO, large rGO, and
nanosized rGO was investigated using 125I labeling. Radio-
activity was detected in the stomach and intestine but not in any
other major organs at 4 h. The signal was no longer detectable
at 24 h, suggesting no intestinal adsorption of PEGylated GO.
In line with these ﬁndings, it was demonstrated that GO (small
and large lateral dimensions) does not penetrate across a fully
diﬀerentiated enterocyte-like Caco-2 cell monolayer.81
The inhalation route is of key relevance for human exposure.
Li et al. studied nanosized GO (lateral dimension: 10−800 nm,
1−2 layer) labeled with 125I to test the biodistribution after
intratracheal instillation.82 The vast majority of the GO sheets
was found in the lungs, decreasing progressively from 10 min to
12 h. Minor amounts were also detected in the blood, liver, and
kidneys. These results could be ascribed to translocation to the
blood either directly from the lungs or via intestinal adsorption as
large amounts of the material were also detected in the stomach
and intestines, potentially due to mucocilliary clearance, swal-
lowing, and redistribution to the gastrointestinal tract.Macroscopic
observation of the blackness of the lungs revealed that materials
were long-lasting (black regions found for up to 3 months).
However, there was a clear decrease of the blackness from day 1
to 90, suggesting clearance from the lungs. Using the same route
of administration, few-layer graphene platelets labeled with
14C (lateral dimension: 60−590 nm; 1−4 nm; 4−6 layers, C/O
ratio: 14.8) were tracked up to 28 days in mice.83 The material
was found primarily in the lungs but also in the stomach and
intestines in much lower amounts, suggesting a mucocilliary
clearance mechanism followed by swallowing of the inhaled
materials. The authors noted a time-dependent decrease in all
investigated organs and a negligible amount of material in the
liver and spleen, suggesting a very limited translocation to the
bloodstream. The observed biodistribution of the graphene
platelets is reminiscent of the biodistribution of 14C-labeled
multiwalled carbon nanotubes following pharyngeal aspiration,
with accumulation in the spleen of mice.84
The impact of subcutanous administration of PBS-based
suspensions of GO (C/O ratio: 2.8) was compared to that of less
oxidized GO (GO-R) (C/O ratio: 3.1) prepared by using less
potassium permanganate during the modiﬁed Hummers’
method.85 No trace metal impurities were detected in the samples.
Unlike GO, there was evidence of early monocyte recruitment at
the interface between GO-R and the subcutaneous tissue and also
inﬁltration of monocytes within the GO-R macrostructure at
day 3. At days 7 and 14, some inﬁltration of the GO macro-
structure bymacrophages and ﬁbroblastswas noted, whereas these
cells had completely inﬁltrated GO-R, with material-laden
macrophages evidenced in both conditions.85 At day 14, there was
also early signs of collagen deposition (ﬁbrosis) for GO-R. By
day 30, the GO macrostructure was fully inﬁltrated by macro-
phages, ﬁbroblasts, and giant cells as expected for a typical
foreign body reaction, whereas the GO-R macrostructure
showed more advanced signs of healing, tissue repair processes,
and extracellular matrix remodeling but without ﬁbrosis. The
authors suggested that the absence of ﬁbrosis could be explained
by the combination of macrophage uptake of the materials, a
mild inﬂammatory response at the edges of the macrostructure,
and indications of clearance from the site of injection.85
Following repeated intraperitoneal (i.p.) injections, graphite
(average size: 3−4 nm) andGO(average size: 8−25nm)powders
resuspended in saline solution without surfactant were found to
form macroscopic aggregates of up to 2 mm in the peritoneal
cavity.86 These materials accumulated at the site of injection but
also randomly throughout the peritoneal cavity without any sign of
clearance or toxicity to the organs or the blood compartment.
Furthermore, in order to assess the inﬂuence of GO oxidation
degree (i.e., C/O ratio) on biodistribution after i.p. administration,
PBS suspensions of GO were compared to those of GO-R.85
An increase in monocytes recruited to the peritoneal cavity was
noticed at day 3 persisting over 2 weeks for GO in comparison to
the less oxidized GO-R. Cells retrieved from the peritoneal
cavity of treated animals and cultured for 12 h in vitrowere more
prone to secrete pro-inﬂammatory cytokines and chemokines in
GO compared to cells retrieved from animals exposed to GO-R.
In addition, GO-R seemed to be cleared more rapidly than GO,
suggesting that persistence/clearance ratemay be linked tomono-
cytic cell recruitment and inﬂammogenicity of these materials.85
To study the biodistribution after i.p. administration of
biomedically relevant materials, diﬀerent types of GBMs were
prepared from GO (lateral dimension: 300−700 nm) to create
PEGylated forms of nanoGO (lateral dimensions: 10−40 nm)
or rGO (lateral dimensions: 50−80 nm) and nano-rGO (lateral
dimensions: 10−30 nm), and the materials were labeled with
125I.80 After 1 day, all the materials were accumulating primarily
in the liver and spleen of exposed mice. However, after 7 days,
while the nanoforms (nGO-PEG and nRGO-PEG) slightly
decreased in the liver and slightly increased in the spleen, the
larger-sized form (RGO-PEG) increased dramatically from
day 1 to day 7 in these two organs. Interestingly, upon
i.p. injection and unlike the PEGylated derivatives, non-
PEGylated GO was found to form aggregates in the peritoneal
cavity. However, this result was only based on macroscopic
observation, as the authors did not perform radioactivity-based
biodistribution analyses for the non-PEGylated materials. Black
materials thought to be the injected materials were found in the
histological sections up to 30 days postinjection. In another
study, PEGylated rGO (lateral dimension: ∼1 μm, thickness:
4−9 nm, C/O ratio: 3.7) were prepared from graphite ﬂakes
following the Hummers’ method to study their biodistribution,
clearance, and toxicological proﬁle in mice upon i.p. admin-
istration.87 Raman spectroscopy complemented by cluster ana-
lysis was used to map the distribution and revealed the presence
of the PEGylated structures in brain, kidney, liver, and spleen.
Following i.p. injection, most materials were found in the spleen
after 3 days. However, whereas material content decreased over
time in the spleen, it increased in the brain at 7 and 14 days,
decreasing by day 21, and increased dramatically in the liver by
day 21. The authors suggested that the materials crossed the
blood−brain barrier, but direct evidence to support this notion
was not presented.87
Bridging Nanosafety and Medicine: Intravenous
Administration. One of the most common routes of
administration for biomedical applications of nanomaterials is
the intravenous (i.v.) route. Considerable research and develop-
ment eﬀorts in nanomedicine have established that shape, size,
and surface charge are the most important physicochemical
parameters determining biodistribution and fate of a nanoma-
terial after i.v. injection.88 Several studies have been published
on the biodistribution of GBMs following i.v. injection. Qu et al.
studied i.v. injection of GO suspended in PBS or GO dispersed
in 1% Tween 80-PBS and noted a higher accumulation in lungs
for GO-PBS (lateral dimension: 300−1000 nm).89 In contrast,
accumulation in the liver was higher for GO-PBS-Tween 80
when compared to that for GO-PBS. Even though these conclu-
sions were based only on the blackness of organs following
treatment and observation of brown/black matter in histological
sections, the results support the idea that better colloidal stability
helps the GO sheets to pass through lung capillaries more easily.
GO sheets functionalized with poly(sodium 4-styrenesulfonate)
(lateral dimension: 300−700 nm, thickness: 1−4 nm) and labeled
with the ﬂuorescent Cy7 dye were used to assess biodistribution
using whole-body live imaging.90 When organs were harvested at
24 h, ﬂuorescence was found only in the liver and bladder.
Fourteen days after injection, there was obvious macroscopic
presence of materials in the lungs, liver, and spleen, which all
appeared black in comparison to corresponding organs from
PBS-treated animals. Materials were still present in these organs
after 180 days, as evidenced by black matter in histological
sections. In a recent study, nonlabeled PEGylated rGO (lateral
dimension: ∼1 μm, thickness: 4−9 nm, C/O ratio: 3.7) was
evaluated for its biodistribution after i.v. injection using Raman
spectroscopy.87 Most materials were found in the liver and
spleen at the earliest time point of 3 days, in agreement with
other studies, but transiently increased in the brain at days 7 and
14 days before decreasing by day 21. The biodistribution
and degradation of oxidized FLG platelets (lateral dimension:
150−220 nm) were studied over 90 days using Raman confocal
imaging.91 The authors reported that the materials (dispersed in
PBS) agglomerated and formed macrostructures of 0.5−10 μm in
the lungs, liver, kidneys, and spleen. The aggregateswere still present
after 90 days despite some signs of degradation at thematerial edges.
Yang et al. reported quantitative evaluation of the biodis-
tribution of GO after i.v. administration using 125I-labeled nano-
sized GO further functionalized with PEG (lateral dimension:
5−50 nm, thickness: 1−2 nm).67 Biodistribution was followed
over 60 days, revealing a higher accumulation in the spleen
compared to that in the liver at all time points and a gradual
decrease of the amount of materials in these reticuloendothelial
system organs. The decrease could be explained by a continuous
clearance as radioactivity was detected in both urine and feces
over the 60 day period, with a higher amount in urine compared
to feces, suggesting glomerular ﬁltration of the material. In a
related study, the biodistribution of nanosized GO function-
alized with PEG was compared to the distribution of nanosized
GO not functionalized with PEG.92 Labeling with 125I was used
to track and quantify the two materials. Both materials
accumulated in the lungs without evidence of clearance during
the tested period (from 10 min to 6 h). Although a very small
amount of the two materials could be found in the spleen, there
was an extensive accumulation of both materials in the liver that
decreased with time. The non-PEGylated GO accumulated
twice as much in the liver when compared to PEGylated GO.
Three months after injection, black matter was still found in
both lungs and liver, with signs of tissue injury and remodeling,
evidenced by collagen deposition (ﬁbrosis). Hence, whereas
PEGylation reduced the accumulation in reticuloendothelial
system organs by extending the blood circulation, this only
marginally alleviated the adverse outcomes upon accumulation
of GO in these organs.92
Sasidharan et al. prepared FLG (lateral dimension: 100−200 nm,
thickness: 0.8 nm) and two derivatives thereof (carboxylated
FLG-COOH and PEGylated FLG-PEG) covalently labeled
with the radioactive marker 99Tc to study their biodistribution
over 24 h.93 FLG-COOH showed higher accumulation in the
lungs over the 24 h period, whereas FLG-PEG accumulated
initially in the lungs, but by 24 h, the material had relocated to
liver and spleen. Using histological sections, the authors
conﬁrmed these results, showing that FLG and FLG-COOH
accumulated in lungs for a long period of time (up to
90 days) causing damage, whereas FLG-PEG gradually exited
the lungs (no sign at 90 days) and did not cause adverse eﬀects in
the lungs. All three materials were also found in spleen, liver, and
kidneys for periods of up to 90 days, and signs of tissue damage
were noted for FLG and FLG-COOH but not for FLG-PEG.93
In another study, small (lateral dimension: 148−160 nm,
1−2 layers, C/O ratio: 2.28) and large (lateral dimension:
556−780 nm, 1−2 layers, C/O ratio: 2.70) GO sheets labeled
with 125I were injected i.v. in mice to study their biodistribution
over 180min.94 A longer blood circulation timewas observed for
small GO when compared to large GO. Conversely, small GO
sheets accumulated mainly in the liver (peaking at 5 min then
progressively decreasing by 180min) with only a limited amount
found in the lungs and spleen (rapidly disappearing from these
organs). In contrast, largeGO sheets weremostly detected in the
lungs, with only a marginal decrease over the 180 min period.
A small amount of large GO was also found in the liver. Finally,
when increasing the dose of injected small GO by a factor of 10,
the authors reported that organ accumulation of GO clearly
shifted from the liver to the lungs, suggesting congestion in the
capillary bed of the lungs possibly due to the formation of
agglomerates of GO sheets.94 These two comparisons (i.e., large
versus small GO and low versus high concentration of small GO)
both support the idea that larger plate-like structures or
agglomerates of smaller plate-like structures are more likely to
be trapped in the lungs following i.v. injection, possibly by
congestion of the blood vessels.
Finally, a series of investigations using radiolabeled GO sheets
functionalized with dioctyltin diacetate (DOTA) to chelate the
radiolabel were executed in the Graphene Flagship (Figure 2).
Single- to few-layer GO sheets (lateral dimension: 100−400 nm
with DOTA, thickness: 2−10 nm) were found to accumulate in
both liver and spleen, with a decrease of radioactivity from 1 to
24 h in the liver and an increase in the spleen.95 Whereas the
amount in the liver was, on average, higher than that in the
spleen at 1 h, it was higher in the spleen compared to the liver at
24 h. Furthermore, biodistribution of these thin GO sheets
(thickness: 1−4 nm without DOTA; 1−10 nm with DOTA)
was compared to thick GO sheets (5−30 nm with DOTA)
obtained by restacking of the thin GO sheets due to aging.40
Thicker materials accumulated to a greater extent than the thin
materials in both liver and spleen over the ﬁrst hour after injec-
tion. Importantly, in both studies, a large amount of radioactivity
was observed in the bladder at early time points. These results
suggested that a large amount of i.v.-injected GO sheets had
undergone renal glomerular ﬁltration, as conﬁrmed by the
transient presence of radiolabeled GO sheets in kidneys and the
detection of GO sheets in the urine, veriﬁed by TEM and Raman
spectroscopy.40 The impact of this extensive renal clearance of
GO sheets on kidney physiology was investigated in a sub-
sequent study.41 No sign of nephrotoxicity or glomerular barrier
dysfunction was identiﬁed despite the translocation of GO
sheets from the blood to the urine. One may assume that the
plate-like GO sheets would need to transiently adopt a diﬀerent
shape (e.g., through folding, crumpling, or wrinkling) in order to
pass through the endothelial fenestra of the glomerular ﬁltration
barrier in the kidney.
Collectively, these studies have shed light on the biodis-
tribution and fate of some GBMs following various admin-
istration routes. Overall, there is evidence that various GBMs are
able to cross physiological barriers, reaching secondary organs
distant from the point of entry. However, due to the scarcity of
the published data and lack of systematic investigations, it is still
too early to reach deﬁnitive conclusions with respect to relation-
ships between physicochemical features and the biodistribution
patterns of GBMs. Moreover, the long-term fate of GBMs at the
site of accumulation is also important. It is acknowledged that
the generation of such data is, however, far from trivial and
requires labeled materials that can be tracked and quantitatively
measured over long periods of time, even as GBMs undergo
transformation or biodegradation in the body.
HAZARD ASSESSMENT OF GRAPHENE-BASED
MATERIALS
Nanomaterials can enter into the body through diﬀerent routes,
and inhalation, dermal adsorption, and ingestion are the most
likely routes of unintended exposure in occupational or envi-
ronmental settings.96,97 Dermal injection is pertinent in the
particular case of tattoo pigments, some of which are nano-
sized.98 Parenteral administration and primarily intravenous
injection is relevant for intentional exposure to nanomaterials
designed for speciﬁc medical applications. Nanomaterials may
subsequently travel through the body and reach sites beyond
their initial portal of entry, as discussed above. However, at some
point, the materials manifest their biological (or toxicological)
eﬀects at the level of speciﬁc target organs.99 The potential
adverse outcomes of nanomaterial exposure have been exten-
sively investigated over the past decade, with particular attention
to common classes of nanomaterials including metal and metal
oxide nanoparticles and carbon-based materials, especially car-
bon nanotubes. These studies have informed us on speciﬁc
material features that contribute to toxicity, for instance, particle
dissolution and the release of toxicmetal ions in the case of certain
metal nanoparticles, or the high aspect ratio and ﬁber-like dimen-
sions in the case of long and rigid carbon nanotubes.6 Hazard
assessment of GBMs has been lagging behind, but in the past
5 years or more, the potential toxicity of GBMs has been explored
in a systematic fashion both in vitro and in vivo, in the EU-funded
Graphene Flagship project and elsewhere. The following sections
provide an overview of the toxicological impact of GBMs on the
immune system, our primary defense against foreign intrusion,
as well as the pulmonary, dermal, cardiovascular, gastrointes-
tinal, reproductive, and central nervous systems, following which
we will discuss the environmental impact of GBMs.
Immune Interactions of Graphene-Based Materials.
The immune system consists of complex molecular and cellular
networks that protect our body from infections and other exo-
genous materials while maintaining tolerance to self-compo-
nents. In the development of new materials, it is fundamental
to assess their impact on the immune system in order to
understand if the presence of such materials can be tackled,
eventually leading to their elimination, or to clarify if the persis-
tence of the materials provokes chronic diseases.100 Macro-
phages are key cells of the innate immune system tasked with
eliminating exogenous and endogenous materials. Therefore, it
is important to know if GBMs aﬀect the viability and/or
activation of macrophages.101 One of the ﬁrst studies to address
this question compared the eﬀect of GO of diﬀerent sizes on
human and murine primary macrophages.102 The three GO
materials tested displayed a dose-dependent cytotoxic eﬀect.
GO of smaller lateral size (130 and 270 nm) were internalized to a
higher extent in comparison to large GO (∼1320 nm), leading to
signiﬁcant eﬀects on cell viability and cell activation (supporting
text and Figure S2). In addition, a speciﬁc interaction of GO
sheets with the cell membrane was noted whereby GO sheets
adopted an arrangement parallel to the cell surface (designated
as the cell “masking” eﬀect).102 Another study based on two GO
materials of diﬀerent sizes (350 and 2000 nm) showed opposite
results.103 Both GO materials had no eﬀect on cell viability and
were internalized by cells in an energy-dependent process but
showed diﬀerent intracellular locations. In addition, except for
IL-10, the release of all other cytokines−chemokines including
IL-6, IL-12, TNF-α, MCP-1, and IFN-γ signiﬁcantly increased
after 2 days in cells exposed to large GO, whereas a weak increase
was measured for small GO.103 The GO materials used in these
two studies were obtained by the same Hummers’ method, and
the only diﬀerence that might explain the contrasting eﬀects is
the number of layers (single-layer GO in the former study and
few-layer GO in the latter study). In another recent study, large
GO showed a stronger adsorption onto the plasmamembrane of
macrophages when compared to small GO, and this elicited
more robust interaction of Toll-like receptors (TLRs) and more
potent activation of the NF-κB pathway.104 Large GO was also
shown to promote M1 polarization, associated with enhanced
production of inﬂammatory cytokines and recruitment of
immune cells. These size-dependent responses to GO were
Figure 2. Biodistribution of GO. PET/CT imaging and tissue distribution of [64Cu]-f-GO-thin, [64Cu]-f-GO-thick, and [64Cu]-EDTA.
(A) Whole-body PET/CT images of C57BL/6 mice injected intravenously with [64Cu]-f-GO-thin (top) and [64Cu]-f-GO-thick (bottom) at
diﬀerent time points (1, 3.5, 24 h). (B) Time−activity curves of major organs of C57BL/6 mice injected with [64Cu]-f-GO-thin, [64Cu]-f-GO-
thick, and control [64Cu]-EDTA. (C)Whole-body PET/CT images of a C57BL/6mouse injected intravenously with the control sample [64Cu]-
EDTA, showing almost complete excretion and no tissue accumulation after 3 h. Reprinted with permission from ref 40. Copyright 2016
Elsevier.
also evidenced in vivo. Hence, large GO was able to generate
inﬂammatory responses signiﬁcantly higher than those of small
GO in mice after intraperitoneal injection.104 Naturally, careful
characterization of the materials is crucial. In particular, endo-
toxin content must be controlled in any studies using immune-
competent cells. Recent work in the Graphene Flagship has
focused on establishing a protocol for sterile production of
GO according to Hummers’ method.26 Using this protocol,
endotoxin-free GO of diﬀering lateral dimensions (50−300 nm
and 10−40 μm, respectively, thickness 1−2 nm) was produced,
and cytotoxicity assessment as well as cytokine proﬁling was
performed using primary human macrophages.39 These studies
showed that small and large GO sheets were readily internalized
by macrophages without any toxicity (Figure 3). Furthermore,
GO did not trigger the production of pro-inﬂammatory TNF-α
in this model.39 However, GO was found to elicit caspase-
dependent IL-1β expression, a hallmark of inﬂammasome
activation, in LPS-primed macrophages. Moreover, a speciﬁc
role of the inﬂammasome sensor, NLRP3, in GO-induced IL-1β
secretion was demonstrated. In contrast to the above-mentioned
study,104 the eﬀects were independent of the lateral dimensions
of GO. These diﬀerences could be ascribed to diﬀerences
between the cell models, i.e., macrophage-like cell lines versus
primary cells, as primary macrophages are far more eﬃcient in
terms of phagocytosis. It thus appears that inﬂammasome
activation leading to IL-1β secretion may transpire for a range of
carbon-based nanomaterials including carbon nanotubes as well
as spherical particles and ﬂat materials such as GO105−109 and
other exogenous materials,100 indicating that the inﬂammasome
functions as a universal “sensor” for xenobiotic agents. It is of
interest to note that the commonly used adjuvant alum also
triggers NLRP3-dependent release of IL-1β in macrophages.110
Thus, in analogy, the immunomodulatory eﬀects of GBMs could
perhaps be harnessed for biomedical uses.111
In a recent study, Li et al. examined a panel of GO materials
prepared by a modiﬁed Hummers’ method comprising pristine,
rGO, and hydrated GO (hGO) in which quantitative assessment
of the hydroxyl, carboxyl, epoxy, and carbon radical contents was
used to study the impact on epithelial cells and macrophages as
well as in the murine lung.112 The authors could show that hGO,
which exhibited the highest carbon radical density, triggered cell
death in THP-1 and BEAS-2B cells with attendant lipid peroxi-
dation of the cell membrane, albeit at relatively high concen-
trations (up to 200 μg/mL). The authors also demonstrated that
hGO was more prone than the other materials to trigger lung
inﬂammation, accompanied by lipid peroxidation in alveolar
macrophages.112 Thus, carbon radical content plays an impor-
tant role for toxicity of GO.
In addition to primary macrophages, the eﬀects of GO were
studied on macrophage-like cell lines. Chen et al. found that
small GO (350 nm) induced the formation of small vacuoles in
RAW264.7 cells without causing apparent cell death.113
Increasing the GO concentration triggered the formation of
more vacuoles and signiﬁcant cell death. In addition, GO treat-
ment provoked TLR signaling and triggered consequent cyto-
kine responses. Molecular analysis identiﬁed that TLR4 and
TLR9 and their downstream signaling mediators MyD88,
TRAF6, and NFkB played critical roles in the GO-induced
inﬂammatory responses.113 This was conﬁrmed in a subsequent
study, in which necrotic cell death was shown to be mediated by
activation of TLR4.114 In contrast, large GO (average lateral
dimension∼1 μm) did not activate TLR2 or TLR4 reporter cell
lines, whereas single-walled carbon nanotubes (with or without a
protein corona) activated TLR signaling with subsequent
chemokine release.115 Protein adsorption biocorona formation
is reminiscent of the process of opsonization whereby micro-
organisms or apoptotic cells are “tagged” for phagocytosis with
antibodies, complement factors, or other soluble proteins.116,117
The impact of protein adsorption or biocorona formation on cell
interactions of GBMs has been explored in a few studies using
human cell lines. Hu et al. prepared GO using Hummers’
method and measured the amount of the model protein, bovine
serum albumin (BSA), adsorbed to GO. They found that the
loading capacity was, respectively, ∼9-fold and ∼1.8-fold higher
than that of BSA to multiwalled and single-walled carbon
nanotubes.118 The data suggested that GO possessed an excep-
tionally high adsorption capacity arising from the 2D structure
that provides a very high surface-to-volume ratio. In addition,
GO possesses many surface defects that could serve as binding
sites for proteins, and this could contribute to the observed
diﬀerences in protein adsorption ability of GO and carbon
nanotubes. In another study, protein adsorption was conﬁrmed
using experimental and theoretical approaches, and the authors
proposed that protein-coated GO sheets lack the capacity for
destructive membrane interactions due to the increase in the
thickness of the GO sheets and reduction of the available surface
area of GO, instead exposing largely hydrophilic surfaces that
may lead to more benign interactions with membrane phos-
pholipids.119 To improve the biocompatibility of pristine GO,
Xu et al. prepared a series of GO derivatives including aminated
GO (GO-NH2), poly(acrylamide)-functionalized GO (GO-
PAM), poly(acrylic acid)-functionalized GO (GO-PAA), and
poly(ethylene glycol)-functionalized GO (GO-PEG) and
compared their toxicity with that of pristine GO.120 Among
these GO derivatives, GO-PEG and GO-PAA induced less
toxicity than pristine GO, and GO-PAA was the most biocom-
patible material. The diﬀerences in biocompatibility were
suggested to be due to the diﬀerential compositions of the
protein corona, formed on their surfaces that determine their cell
interactions and pro-inﬂammatory eﬀects.120 In another recent
study, coating of GO with complement factor H aﬀorded almost
complete protection (>90% reduction) against complement
activation, suggesting that a “stealth” eﬀect can be achieved
through purposeful biocorona formation.121 By contrast, coating
of GO with serum albumins achieved moderate protection
(∼40% reduction), whereas immunoglobulin G ampliﬁed com-
plement activation by several-fold.
PEGylation was shown in several studies to reduce the
cytotoxic eﬀects of GO on macrophages.122−124 However, a
recent report suggested that PEGylation of small GO ﬂakes
(single-layer,∼200 nm in lateral size) resulted in the stimulation
of a potent cytokine response, despite not being internalized by
macrophages.125 The authors performed extensive molecular
dynamics simulations of pristine and PEGylated GO in the
presence of lipid membranes. PEGylated GO appeared to
preferentially adsorb onto and partially insert into cell mem-
branes, thereby amplifying the interactions with stimulatory
surface receptors. The authors also put forward the hypothesis
that the integrin αvβ8 is involved in initiating signal transduction
related to the membrane binding of PEGylated GO.125 Overall,
these results are surprising as they suggest that PEGylation does
not lead to passivation but, instead, might lead to macrophage
activation. Clearly, not only the characteristics of the parent
material (GO) but also the surface modiﬁcation (i.e., the mor-
phology and density of PEG chains on the surface of GO) should
be carefully evaluated, and endotoxin contamination should be
excluded.
Macrophages belong to the front line of the innate immune
defense against pathogens or foreign materials.111 Most studies
on macrophages have been performed using macrophage-like
cell lines or monocyte-derived macrophages. However, alveolar
macrophages are likely one of the ﬁrst cell types, along with
epithelial cells, to interact with GBMs, reaching the lungs after
pulmonary exposure. Studies on alveolar macrophages are scarce,
but Weimann et al. performed studies using the rat NR8383
alveolar macrophage cell line as a model to predict the pulmonary
toxicity of 18 diﬀerent inorganic nanomaterials including graphite
nanoplatelets and distinguish active from passive nanomateri-
als.126 Graphite nanoplatelets (<30 μm ﬂakes) were classiﬁed as
in vitro passive materials. Neutrophils are among the ﬁrst cells to
be recruited in the airways upon pulmonary exposure to GBMs
Figure 3. Macrophage uptake of GO. Primary human monocyte-derived macrophages readily ingest GO without ultrastructural signs of acute
toxicity. Macrophages were incubated for 3 h with or without small or large GO (50 μg/mL). TEM images (scale bar: 2 μm) show (a) control
cells, (b) cells exposed to GO-S, and (c) cells exposed to GO-L. Internalized GO can be seen in panels (b,c). Higher-magniﬁcation micrographs
(scale bar: 1 μm) show (d) control cells, (e) cells exposed to GO-S, and (f,g) cells exposed to GO-L. The asterisk in panel (e) indicates GO
sheets that are undergoing internalization. The asterisk in panel (f) shows a large aggregation of GO inside the cell, whereas the image in panel
(g) shows the presence of GO sheets at the plasma membrane of the cell as well as GO internalized within the cell. The asterisk marks a
mitochondrion, for comparison. Finally, at higher magniﬁcation (scale bar: 200 nm), the micrographs in panels (h,i) show internalized GO-S
and GO-L, respectively. Reprinted with permission from ref 39. Copyright 2018 Wiley-VCH Verlag GmbH & Co.
and also play a key role in inﬂammation in many other tissues.
Interestingly, a recent study has shown that when GO sheets
interact with isolated human neutrophils, this triggers a dose-
dependent loss of cell viability and size-dependent formation
of neutrophil extracellular traps (NETs).127 NETs consist of
nuclear chromatin decorated with granule proteins such as
neutrophil elastase (NE) and myeloperoxidase (MPO), and these
structures are normally deployed by neutrophils for extracellular
destruction of pathogens. In the latter study, the eﬀects of GO
were attributed to cholesterol oxidation in the plasma mem-
brane, as evidenced by time-of-ﬂight secondary ion mass spec-
trometry (ToF-SIMS) of exposed cells.127 The latter study
underscores the importance of direct membrane interactions of
2Dmaterials and implies that immune cells may respond to such
materials in amanner that is comparable with immune responses
to bacteria and fungi.
In contrast to GO, there are relatively fewer studies on graph-
ene and its eﬀects on the immune system. As graphene is too
hydrophobic to obtain homogeneous dispersions in aqueous
solutions, it is necessary to use appropriate biocompatible sur-
factants or coating molecules. In a recent study, Graphene
Flaghsip scientists discovered that FLG obtained by solvent-free
ball-milling treatment of graphite in the presence of melamine,
subsequently dispersed in cell culture medium, is able to speci-
ﬁcally kill monocytes while preserving the viability of macro-
phages.128 The capacity of FLG to trigger monocyte cell death
was exploited to selectively kill monocytoid cancer cells isolated
from patients aﬀected by myelomonocytic leukemia. One of the
most biocompatible surfactants used to disperse nanomaterials
is pluronic F108. It has been found that exposure of macro-
phages to graphene in 1% pluronic decreases cell viability in a
dose-dependent manner. This graphene signiﬁcantly stimulated
the secretion of Th1/Th2 cytokines and chemokines, and the
morphology of naiv̈e macrophages was altered, with reduced
capacity to adhere to the extracellular matrix and attenuated
phagocytic capacity.129 The same type ofmaterial, again dispersed
in 1% pluronic, can induce cytotoxic eﬀects with dissipation of the
mitochondrial membrane potential and increase of intracellular
reactive oxygen species (ROS), resulting in apoptosis.130
Graphene or graphene that had undergone a direct oxidative
process to introduce oxygenated species on its surface was also
tested upon dispersion in physiological medium. Both materials
do not cause any premature immune cell activation or
suppression up to 75 μg/mL after 72 h of incubation. Macro-
phages showed relatively high intracellular uptake of oxidized,
hydrophilic graphene compared to the hydrophobic graphene,
which was found to be mainly retained on the cell surface and
induced ROS-mediated apoptosis above 50 μg/mL.131 When
graphite is only partially exfoliated, a material in the micrometer
lateral size range composed of multilayers of stacked graphene
sheets (incorrectly called nanographite) can be isolated. Further
treatment with strong acid generates oxidized (micro)graphite.
Both types of (micro)graphite were shown to trigger a weak
cytotoxicity with dose-dependent pro-inﬂammatory cytokine
release.132 Li et al. investigated the interactions of graphene and
FLG microsheets with macrophages and other cell types and
with model lipid membranes by combining molecular dynamics
simulations with confocal ﬂuorescence imaging and electron
microscopic imaging.133 The imaging experiments suggested
edge-ﬁrst uptake of FLG into cells. The authors speculated that
the ability of large graphene microsheets to penetrate and enter
cells, documented experimentally and through simulations,
may lead to cytoskeletal disruption, impaired cell motility,
compromised epithelial barrier function, or other “geometric
and steric eﬀects”.133 However, the lack of cell viability tests
precluded any quantiﬁcation of possible cellular damage.
High-throughput technologies have revolutionized the ana-
lysis of immune cells and their complex interactions. Consequently,
a comprehensive analysis of how the immune system interacts with
nanomaterials is only possible by the adoption of system biology
approaches and high-throughput tools that permit multiplex
analysis of cell type, cell activation state, and soluble mediators
of stimulation/inhibition of immune cells. In a recent study
conducted in the framework of the JTC 2015 FLAGERA call
(G-Immunomics project), Orecchioni et al. investigated the
eﬀects on human immune cells of two types of thoroughly char-
acterizedGO sheets, diﬀering in their lateral size distribution [small
GO (GO-S) 100−500 nm, and large GO (GO-L) 1−10 μm], by
using a wide range of assays including whole-genome microarray
analysis and single-cell mass cytometry.134 Exposure of peripheral
blood mononuclear cells from healthy donors to small GO
sheets was found to have a more signiﬁcant impact when com-
pared to large GO sheets, as reﬂected in the upregulation of
critical genes implicated in immune responses and the release of
the pro-inﬂammatory cytokines, IL-1β and TNF-α. These
ﬁndings were conﬁrmed by genomics approaches using Jurkat
T cells as representative for the adaptive immune system and
THP-1 cells, a monocytic cell line representative of the innate
immune system. The microarray studies identiﬁed the activation
of some relevant immune pathways correlated with T cell
chemotaxis/T cell migration, regulation of T cell chemotaxis, and
leukocyte chemotaxis pathways.134 This work suggested that small
GO could elicit an innate and also an adaptive response boosting a
strong recruitment of immune cells, potentially providing a ﬁrst
step toward unconventional strategies for nanobased immuno-
therapeutics. Moreover, by using single-cell mass cytometry,
multidimensional cytometry experiments in which simultaneous
investigations of 15 immune cell populations with interrogation of
30 markers at the single-cell level was possible.134 GO caused a
broad, non-cell-speciﬁc activation triggering the production of
all cytokines analyzed in a wide variety of cell populations.
Following surface functionalization of the two GO with amino
groups (GO-NH2), these materials resulted more speciﬁc,
aﬀecting the production of only a few cytokines in selected cell
subpopulations. Taken together, these studies conﬁrmed that
the functionalization of GO signiﬁcantly aﬀected the number of
transcripts altered by graphene.134 Moreover, functionalization
of GO with amino groups increased the biocompatibility. The
study lays the foundation for an innovative approach for
multidimensional, high-throughput analysis of the eﬀects of
GBMs on immune cells (Figure 4).
Overall, when comparing the results of diﬀerent studies on
GBMs (above, and refer to Supporting Information), the toxicity
of this class of materials toward macrophages, in particular,
appears to be less pronounced as compared to the eﬀects of
carbon nanotubes. For other immune-competent cells, there are
only a few studies available. However, studies performed in the
Graphene Flagship have revealed diﬀerences in toxicity depend-
ing on the lateral dimensions of GBMs, though this hardly
qualiﬁes as a “ﬁber-like” eﬀect. Furthermore, as we shall discuss
in the following section, GBMs are susceptible to biodegrada-
tion, meaning that these materials are not biopersistant.
Biodegradation of Graphene-Based Materials. Biode-
gradation of nanomaterials is a topic of considerable relevance
both in toxicology and in nanomedicine. The very fact that some
carbon-based nanomaterials such as single-walled carbon
nanotubes are susceptible to degradation by immune cells sets
them aside from asbestos, which is nondegradable in biological
systems.9 Although some research has been done on GBMs in
this regard, the description of the structural characteristics of the
diﬀerentmaterials used in each biodegradation study is crucial to
rationalize the results. Here, we focus our discussion on the
degradation of GBMs, emphasizing the role of the three funda-
mental material properties, i.e., the number of graphene layers,
the average lateral dimension, and the atomic C/O ratio
(Figure 1)22 (supporting text and Figure S3).
Kotchey et al. found that low concentrations of horseradish
peroxidase (HRP) could degrade GO, whereas reduced GOwas
not aﬀected.135 The diﬀerent interactions between GO or rGO
with the active site of HRP was proposed as the main reason for
these diﬀerences in susceptibility to degradation. Zhang et al.
studied the eﬀect of graphene, GO, and rGO on the stability of
Figure 4. Dissecting the immunological impact of graphene using single-cell mass cytometry. SPADE (spanning tree progression analysis of
density-normalized events) clustering algorithm analysis of signiﬁcantly secreted cytokines. The tree plots show the diﬀerent immune cell
subpopulations, and the size of each cluster in the tree indicates the relative frequency of cells that fall within the dimensional conﬁnes of the
node boundaries. Node color is scaled to the median intensity of marker expression of the cells within each node, expressed as a percentage of
the maximum value in the data set: (a) IL-6; (b) TNF-α, and (c) MIP-1β for GO (left) and GO-NH2 (right). Reprinted with permission from
ref 134. Copyright 2017 Nature Publishing Group.
HRP. Interestingly, whereas both graphene and GO were found
to reduce enzyme stability, rGO was able to preserve the
catalytic activity of the enzyme, presumably by scavenging
superoxide radicals, thereby protecting the enzyme from
oxidation.136 Li et al. examined how surface coatings aﬀect the
cytotoxicity and biodegradation of GO and its derivatives.137
Although pristine GO triggered signiﬁcant toxicity to macro-
phage-like U937 cells (albeit at very high doses, i.e., 100 or
200 μg/mL), coating of GO with PEG or BSA attenuated the
toxicity. On the other hand, both PEG- and BSA-coated GO
were found to be resistant to HRP-induced biodegradation.137
To circumvent this, the authors conjugated PEG to GO via a
cleavable disulﬁde bond, obtaining GO-SS-PEG with negligible
toxicity and considerable degradability when incubated with
HRP and H2O2. Functionalization can be also exploited to
design systems able to “attract” enzymes toward the modiﬁed
GO surface. In a recent study from the Graphene Flagship,
Kurapati et al. demonstrated enhanced degradation of GO when
functionalized with coumarin and catechol, which are natural
ligands of HRP.138 Kurapati et al. also demonstrated thatMPO, a
human enzyme secreted by activated neutrophils, can degrade
GO. In this case, aqueous dispersibility of thematerial was found
to play a crucial role in the biodegradation process.139 Three
diﬀerent GOs with similar lateral dimensions and C/O ratios but
diﬀerent thicknesses were evaluated, and the two highly dispersed
materials were completely or almost completely degraded at 24 h,
whereas only limited structural changes occurred in the case of
the aggregated sample.139 More recently, Graphene Flagship
scientists have reported that single-layer GO sheets of diﬀering
lateral dimensions could be readily degraded by isolated human
neutrophils stimulated to produceNETs or activated to undergo
degranulation with the release of MPO.140 In addition, the
degradation byproducts of GO were shown to be nongenotoxic
to human lung cells. Based on these in vitro results, it is possible
to suggest that inhalation of GO with the recruitment of
neutrophils and macrophages may potentially lead to intra- or
extracellular digestion of GO, which could mitigate the overall
pulmonary impact, as previously shown for certain carbon
nanotubes.9 Indeed, it was demonstrated that oxidation and
clearance of single-walled carbon nanotubes from the lungs of
MPO-deﬁcient animals after pharyngeal aspiration was markedly
less eﬀective after 28 days, whereas the inﬂammatory response
was more pronounced than in wild-type C57Bl/6 mice.141
Further studies to assess the in vivo degradation and clearance of
GO are warranted.
Girish et al. assessed the degradation of graphene in vivo.91
Prior to administration, the carboxyl-functionalized graphene of
lateral size ∼200 nm was shown to be well-dispersed in aqueous
medium, but 24 h postinjection, large aggregates of sizes up to
10 μm could be detected in various organs. Confocal Raman
imaging was conducted to identify the gradual development of
structural disorder occurring over a period of 3 months in lung,
liver, kidney, and spleen of mice exposed by i.v. injection to
graphene. The authors argued that graphene degradation was
mainly orchestrated by macrophages in the diﬀerent organs.91
The speciﬁc mechanism involved was not disclosed, but it is
relevant to note that previous studies have shown that single-
walled and multiwalled carbon nanotubes can be digested by
macrophages through a peroxynitrite-driven pathway that
depends on the activation of NADPH oxidase and iNOS.142,143
The degradation potential of GO has been also studied using
acellular oxidative systems such as the photo-Fenton reaction144
or sodium hypochlorite (NaClO), colloquially known as
bleach.145 In the former case (oxidation potential of OH● =
2.80 V), only 3 days were suﬃcient to completely degrade GO.144
Using FTIR, mass spectrometry, and NMR, potential structures
for the oxidation products, which consisted of oxidized
polycyclic aromatic hydrocarbons, were proposed. Seven days
were instead required to degrade GO using 1% NaClO in water
(oxidation potential HClO/Cl− = 1.48 V).145 However, GOwas
degraded more rapidly than oxidized multiwalled carbon nano-
tubes. Microbial degradation is another promising way to
degrade GBMs as this does not require controlled conditions
such as controlled temperature and pH. Lalwani et al. reported that
oxidized and reduced GO nanoribbons (GO-NR and rGO-NR)
were degraded by lignin peroxidase, an enzyme released from
white rot fungus.146 Raman spectroscopic analysis indicated
that, within 96 h, GO-NR and rGO-NR were completely and
partially degraded by lignin peroxidase, respectively. Further-
more, Liu et al. demonstrated that naphthalene-degrading
bacteria could degrade graphitic materials due to a mechanism
based on electron transfer.147 Interestingly, graphite, GO, and
rGO showed diﬀerent rates of oxidation and degradation after
being incubated with the bacterial strain for 14 days. Taken
together, these studies suggest the potentiality of degrading
GBMs released in the environment.
In conclusion, studies conducted in the past several years have
clearly shown that intra- and extracellular degradation of GO can
be executed by immune cells. However, more research is required
on the degradation of other GBMs with deﬁned properties using
relevant in vitro and in vivo models to better understand the
possible risks of long-term biopersistence of such materials and
in order to make them safer-by-design.
Dermal Eﬀects of Graphene-Based Materials. The skin
is the major barrier between the human body and the envi-
ronment, and it can be considered as one of the most important
exposure sites for GBMs, not least in the occupational
setting.148,149 Given the chemical nature of GBMs, skin irritation
may be considered as the most feasible outcome after cutaneous
exposure. However, skin sensitization cannot be excluded in
light of the propensity of GBMs to interact with proteins.150,151
Indeed, cutaneous contact with related materials such as
graphite and carbon nanotubes has been associated with skin
disorders, e.g., contact dermatitis.152,153
Limited toxicological data are currently available for GBMs at
the skin level. The majority of studies are in vitro studies on skin
keratinocytes and/or ﬁbroblasts. Liao et al. evaluated the impact
of a panel of diﬀerent GOs obtained by Hummers’ method
(lateral dimension: 871−1678 nm; thickness: 1−10 nm) and
graphene sheets produced by dehydration process of GO
(average lateral dimension: 4312 nm; thickness: up to 10 nm)
on skin ﬁbroblasts.66 The authors demonstrated that, after 24 h
exposure, graphene induces a cytotoxic eﬀect higher than that of
GO, probably due to a more pronounced tendency to aggregate.
In subsequent studies, carried out in the framework of the
Graphene Flagship, the eﬀect of three GOs obtained by
Hummers’ method (lateral dimensions: 622−979 nm) and
one FLG sample (average lateral dimension: 552 nm) in spon-
taneously immortalized human keratinocytes was evaluated.154
All materials induced a signiﬁcant cytotoxic eﬀect, albeit with
diﬀerent potencies. The cytotoxic potential was mainly depend-
ent on the oxidative state of the GBMs, with FLG being signi-
ﬁcantly less cytotoxic than GO. In addition, using various in vitro
assays, the results demonstrated that FLG and GOs were able to
induce a signiﬁcant mitochondrial dysfunction after a sustained
plasmamembrane damage.154 These eﬀects seem to be dependent
on a signiﬁcant production of reactive oxygen species through a
selective activation of ﬂavoprotein-based oxidative enzymes, such
as NADH dehydrogenase and xanthine oxidase, by FLG (average
lateral dimension: 391 nm) and GO (average lateral dimension:
979 nm).155 These eﬀects are likely due to a closer interaction
with the plasma membrane, as suggested in a previous study
using molecular dynamics simulations as well as electron micro-
scopy imaging, showing the ability ofmicrosize graphene to interact
with the plasma membrane of primary human keratinocytes.133
Only one in vivo study has been published thus far on dermal
eﬀects of GBMs. In this study, GO (lateral dimension:
250−1750 nm; thickness: 2 nm) was injected into the dermis
of the growing feather sites of chickens, providing a minimally
invasive model for the investigation of the local immune/
inﬂammatory reaction.156 The response was evaluated based on
the type and relative amount of leukocytes at the site of intra-
dermal injection. The results showed an increased inﬁltration of
lymphocytes and macrophages at the injected site up to 2 days
postinjection decreasing gradually between days 4 and 7.
Qualitative and quantitative aspects of the leukocyte inﬁltration
suggested a cell-mediated immune response, probably initiated
by GO interactions with host proteins.156 Even though the
available data are not suﬃcient to deﬁne the relevant toxicity of
GBMs after cutaneous exposure, their ability to initiate an immune
response after dermal injection raises concern for GBM uses.
Overall, the currently available literature, limited to one in vivo
and a few in vitro studies, is not suﬃcient to draw any conclu-
sions on the hazard related to dermal exposure to GBMs.
Pulmonary Eﬀects of Graphene-Based Materials.
Among the diﬀerent routes of unintended exposure to
nanomaterials in occupational settings, inhalation is the route
of highest concern. A long history of studies on the impact of air
pollution and ultraﬁne particles on human pulmonary health has
supported the notion that nano- and micron-sized particles may
cause harm to the lungs (reviewed in ref 97). GBMs are not
exempt from these concerns as these materials are commercially
available as volatile powders often referred to as nanopowders or
suspensions/dispersions of graphene nanoplatelets (GNPs),
GO, or rGOmost often water-based. This section will focus
on studies investigating GBM pulmonary eﬀects after exposure
of the pulmonary system via the common routes (i.e., intra-
tracheal, oropharyngeal, inhalation) or using models reproducing
potential pulmonary exposure consequences (i.e., intrapleural,
intraperitoneal). Pulmonary eﬀects of GBMs injected intra-
venously will not be discussed here, as this topic has been
reviewed previously by others.18,157
Roberts et al. evaluated the pulmonary and systemic toxicities
of three types of graphite plate-like structures (20 μm/72 layers,
5 μm/84 layers, 1−2 μm/28 layers) in mice following
pharyngeal aspiration.158 Toxicity was dose-dependent, with
the lowest dose (4 μg/mice) inducing no toxic response,
whereas the highest dose (40 μg/mice) caused size-dependent
lung inﬂammation. The adverse pulmonary and systemic eﬀects
observed at early time points at the highest dose showed signs of
resolution for all materials. Despite the persistence of all three
materials, neither ﬁbrosis nor granulomatous lesions were
observed. The authors highlighted that not only size but also
surface reactivity and agglomeration are important to consider
when studying GBMs.158 Schinwald et al. studied large graphene
platelets (1−10 μm, 10 layers) following oropharyngeal instil-
lation in mice to assess their pulmonary eﬀects.159 At 1 day, large
numbers of polymorphonuclear leucocytes, mainly neutrophils
and eosinophils, were recruited into the lungs, and cytokine
levels were increased. Due to the shape of graphene platelets, the
authors hypothesized that their uptake by macrophages could be
impaired, leading to “frustrated phagocytosis”. Indeed, exami-
nation of pleural macrophages of exposed mice showed signs of
frustrated phagocytosis after exposure to graphene platelets,
whereas nanoparticulate carbon black was fully taken up by
cells.159 However, using the same materials, the same authors
did not observe inﬂammation at 7 days or 6 weeks postexposure
following pharyngeal aspiration.160 At these time points, there
were no longer any signs of inﬂammation in the lungs. Similarly,
there was no ﬁbrosis despite the obvious persistence of large
amounts of graphene platelets in the airways. Importantly, there
was no sign of the materials in the pleural cavity (neither after
1 day nor after 6 weeks). This result thus indicated that graphene
platelets were not able to translocate into the pleural space, thus
preventing them from inducing granuloma on the pleural
mesothelium, a hallmark of asbestos pathogenicity. On the other
hand, when injected directly into the intrapleural space, graph-
ene platelets induced the formation of large granuloma (indicative
of inﬂammation) at the surface of the pleural mesothelium and
non-adhesive rosette-like cell/particle agglomerates (indicative of
frustrated phagocytosis) in the pleural cavity.159
Mao et al. administrated FLG (lateral dimension: 60−590 nm;
thickness: 1−4 nm, C/O ratio: 14.8) to mice via intratra-
cheal aspiration83 (supporting Figure S4). Whereas the low dose
(5 μg/animal) did not cause any injury to the lungs, the high dose
(50 μg/animal) induced cell recruitment and lung damage.
Histopathological analysis of the lung sections after 1 day con-
ﬁrmed the absence of damage after exposure to low doses,
despite the material burden. In contrast, lungs exposed to the
high dose of FLG showed interstitial and parenchymal damages,
with a large amount of macrophages in alveoli at day 1. The lungs
exposed to a high dose of FLG recovered slowly, with damage
still present after 7 days but disappearing by day 28, despite a
persistent burden estimated at almost half of the initial dose.83
Similarly, persistence in the lungs up to 28 days after single bolus
exposure was observed in another study of FLG nanoplatelets
(average dimension: 325 nm; thickness: 3−4 nm).161 Despite
the persistence of the materials, no lung lesions (e.g., granuloma
or ﬁbrosis) were observed. In a follow-up study, animals were
exposed to similar FLG and assessed at day 90 after a single
bolus exposure.162 There was an increase of the percentage of
lymphocytes in BAL ﬂuid of animals treated with the lowest
doses and an increase in the total number of cells and apoptotic
cells in the BAL ﬂuid of animals treated with the highest dose.
Elevated levels of cytokines and chemokines were also found
90 days after exposure in the high-dose-treated animals. The
authors concluded that the pulmonary persistence of materials,
in part within macrophages, was the reason for the pulmonary
and systemic immune responses observed at the highest dose
tested.162
The pulmonary eﬀects of GNPs were also evaluated in ani-
mals exposed via inhalation, which is the gold standard method
for assessing pulmonary toxicity. In a ﬁrst study, rats were
exposed for 6 h/day for 5 days at 0.68 or 3.86 mg/m3 graphene
(lateral size: 550 nm, thickness: 8 μm, C/O ratio: 9.8), resulting
in deposited doses of 18 or 102 μg, respectively.163 Despite the
observation of graphene-laden macrophages, no eﬀects on BAL
cell composition or LDH release (indicative of lung damage)
were seen at 1, 3, 7, or 28 days postexposure. In a second study
by the same authors, rats were exposed to GNP (lateral sizes up
to 2 μm, 20−30 layers, C/O ratio: 25) for 6 h/day, 5 days/week,
for 4 weeks, at 0.12, 0.47, and 1.88 mg/m3, leading to an
estimated deposited doses of 12, 50, and 198 μg, respectively.164
The animals were assessed at 1, 28, and 90 days after exposure.
Inhaled materials were found in macrophages, but no signs of
inﬂammation were noticed at any time points, regardless of the
doses applied. Interestingly, inhaled materials were also found in
the mediastinal lymph nodes, suggesting translocation of
materials from the airways to the lymphatic system.164 Trans-
location of GBMs to mediastinal lymph nodes was also observed
after exposing animals to various types of pristine or function-
alized GNPs by intratracheal instillation.165 Moreover, an early
inﬂammatory response with recruitment of neutrophils was
observed, and this was more pronounced for the amino-
functionalized materials.
Oxidized graphene derivatives have also been investigated for
their potential impact on the lungs. Nanoscale GO sheets
(lateral dimension: 10−800 nm, 1−2 layers) were intra-
tracheally instilled in mice, and their impact on lungs was
assessed at various time points from 1 day and up to 3 months.82
Inﬂammation appeared already at day 1, with a dose-dependent
recruitment of immune cells including neutrophils, along with
signs of acute lung injury. The peak of the response was observed
at 2 days, returning to levels close to, but still above, control
levels by day 7. Material-laden macrophages started to appear in
lung sections by day 7 and were still present in the lungs at
3 months, though a decrease in the blackness of the lungs from
day 1 to day 90 suggested an ongoing clearance process. The
pulmonary eﬀects of GO sheets dispersed in water (0.5−2 nm/
1 nm) were compared to those of GNPs dispersed in water
(1.2−5 nm/1−5 nm) or in 2% pluronic F108 in water (1.2−
5 nm/1−5 nm).68 GO-treated animals exhibited severe
pulmonary inﬂammation but no signs of ﬁbrosis. In contrast,
GNPs were less inﬂammogenic, and this was further minimized
when the GNPs were well-dispersed using the block copolymer
pluronic. The authors suggested that oxidation of graphene is a
major contributor to its pulmonary toxicity.68 This is in contrast
to a previous study in which colloidally stable dispersions of
single-layer GO (<500 nm) were injected i.p. into mice without
signs of inﬂammation or granuloma formation onto the peri-
tonealmesothelium.35 Single intratracheal administration of either
GO sheets (lateral dimension: 2−3 μm, thickness: 1−2 nm, C/O
ratio: 1.4) or rGO sheets (lateral dimension: 1−2 μm, thickness:
1−2 nm, C/O ratio: 8.5) was performed in mice.166 GO sheets
induced a strong neutrophil inﬂux at 18, 54, and 162 μg/mouse,
1 and 3 days postexposure. This was paralleled by a pulmonary
acute phase response. In contrast, rGO sheets induced
signiﬁcantly less neutrophil inﬂux, and neutrophil inﬂux was
only statistically signiﬁcantly increased at 162 μg/mouse.
However, all three dose levels induced statistically signiﬁcantly
increased neutrophil inﬂux at 90 days postexposure. Carbon
black nanoparticles “Printex 90” which have a speciﬁc BET
surface area similar to the studied rGO sheets were included as
benchmark particles. The inﬂammatory response to rGO sheets
was lower than or similar to the response to carbon black,
whereas on day 1 and 3, the inﬂammatory response to GO sheets
was stronger than the inﬂammatory response to carbon black.
Additionally, DNA damage in BAL ﬂuid cells was found for both
GO and rGO sheets, whereas no genotoxicity was observed in
lung or liver tissues.166 This is interesting as it contrasts with
previous results obtained in vitro for the same GO and rGO
materials, using the murine lung epithelial cell line FE1.167
Obviously, lung epithelial FE1 cells are very diﬀerent from BAL
cells (i.e., a mixture of immune-competent cells), and this simple
diﬀerence could explain the discrepancy between the two studies.
However, similar genotoxic eﬀects have been reported for some
multiwalled carbon nanotubes.168,169 On the other hand,
degradation of GBMs has been demonstrated in vitro and
in vivo,10 and a recent study showed no genotoxicity in lung cells
exposed to the degradation products following MPO-mediated
digestion of GO.140
GBMs are produced with a range of diﬀerent lateral dimen-
sions, and it is important to investigate the role of size on
pulmonary eﬀects, not least because other carbon-based materials
including carbon nanotubes clearly display a size-dependent
toxicity.6Ma et al. produced single-layerGO sheets of three distinct
lateral dimensions (50−400, 300−800, and 700−1400 nm),
though only the larger and smaller ones were tested for their
pulmonary eﬀects in mice.104 Nevertheless, a clear size-depen-
dent response was observed 3 days after exposure for all para-
meters tested (i.e., LDH and protein content, cytokine levels, cell
recruitment in BAL ﬂuid), with the larger materials causingmore
adverse eﬀects than the smaller ones. This is in apparent contrast
to a recent in vitro study using primary human macrophages, in
which neither small (50−300 nm) or large (10−40 μm) GO
sheets were found to trigger inﬂammatory cytokines, unless the
cells were primed ﬁrst with LPS.39 Unfortunately, the authors of
the aforementioned in vivo study performed the investigations
only after 3 days and did not report on the histopathological
analysis, leaving open the question of long-term consequences of
the acute inﬂammatory response, including potential induction
of ﬁbrosis. In contrast, Wang et al. compared large (1676 nm)
versus small (179 nm) GO sheets and BSA-dispersed (640 nm)
versus pluronic F108 dispersed (45 nm) GNPs and reported that
all materials, with the exception of the GNPs dispersed in
pluronic F108, induced collagen deposition/ﬁbrosis 21 days
after pharyngeal aspiration.106 Overall, F108-dispersed GNPs
were less inﬂammogenic and not ﬁbrogenic compared to BSA-
dispersed GNPs, which were both inﬂammogenic and ﬁbro-
genic, whereas both small and large GO sheets were inﬂam-
mogenic and ﬁbrogenic, and large GO sheets induced more
pronounced eﬀects than the small GO sheets. Recent studies
performed in the Graphene Flagship have revealed similar size-
dependent responses in the lungs ofmice exposed via the intranasal
route to a single administration of small (lateral dimension:
170 nm, thickness: 1 nm, C/O ratio: 2.2) or large (1723 nm, 1 nm,
C/O ratio: 2.2) GO sheets.170 In this study, the large GO sheets
inducedmore immune cell inﬁltration (primarily neutrophils) in
the lungs at day 1 when compared to small GO sheets, leading to
the formation of granuloma by day 7, which increased by day 28.
However, in contrast to the previous study,106 no ﬁbrosis was
observed after 28 days despite the presence of granulomas in the
lungs of animals treated with large GO.170 In another recent
study, the degree of surface oxidation of GO was evaluated in
relation to pulmonary toxicity.112 Hence, GO sheets (lateral
dimension: 334.1 nm, 1 layer, C/O ratio: 1.72) were compared
to rGO sheets (lateral dimension: 549.2 nm, 3 layers, C/O ratio:
5.06) or hydrated GO sheets (329.8 nm, 3 layers, C/O ratio:
2.60). The hydrated materials produced the highest amount of
carbon radicals and induced the highest production of ROS,
whereas the reduced materials induced the lowest amount of
free radicals and ROS. The pulmonary impact was evaluated
in mice 40 h after a single pharyngeal aspiration exposure at
2 mg/kg for each of the three materials. The GBMs with the
highest pro-oxidative potential (hydrated GO) caused more
lung damage in this acute model.112 Furthermore, GO and GNP
were aerosolized onto the lung epithelial tissue surface in a 3D
human lungmodel.171 Subsequent evaluation showed that exposure
to GBMs at two diﬀerent exposure concentrations (∼300 and
∼1000 ng/cm2) did not elicit any adverse eﬀects in the 3D lung
model.
Finally, whereas in vivo studies are typically performed in
healthy laboratory animals, susceptible models of disease should
also be investigated. Shurin et al. employed a classical model of
asthma in which ovalbumin (OVA) is used as allergen to study
the impact of single-layer GO sheets (lateral dimension: 20 nm
to 5 μm).172 GO instilled oropharyngeally (80 μg/mouse) was
found to modulate the allergic inﬂammation by decreasing the
Th2-mediated immune response, leading to increased airway
hyper-reactivity and remodeling. Interestingly, without coex-
posure to allergens, GO sheets did not induce any signiﬁcant
adverse eﬀects. Exposure to GO during sensitization with OVA
decreased eosinophil accumulation and increased the recruit-
ment of macrophages in BAL ﬂuid. In addition, GO increased
alveolar macrophage production of the asthma-associated
chitinases, CHI3L1 and AMCase.172
In conclusion, it appears that the extent of pulmonary impact
is directly correlated to the speciﬁc physicochemical properties
of the tested materials. Dimensions seem once again to be an
essential driver of the biological response to GBMs. Of note,
only few studies so far have reported the induction of ﬁbrosis, a
hallmark of lung damage, after pulmonary exposure to GBMs.
The lack of pulmonary ﬁbrosis is an important diﬀerence when
comparing GBMs with pathogenic multiwalled carbon nano-
tubes (i.e., those classiﬁed by IARC as potential human
carcinogens).6 However, further systematic investigations
looking at long-term impact of GBMs are warranted to fully
address this issue.
Cardiovascular Eﬀects of Graphene-Based Materials.
Over the past 20 years, there has been compelling evidence of a
relationship between air pollution, inhalation of ﬁne and ultra-
ﬁne particles, their impact on the lungs, and cardiovascular
diseases.173,174 Hence, inﬂammation and oxidative stress in the
pulmonary system resulting from the inhalation of particulate
matter are cited as probable causes for collateral eﬀects on the
cardiovascular system. Despite the established connection between
pulmonary exposure and cardiovascular disease, information
regarding the possible cardiovascular impact of inhalable nano-
materials remains limited.175 For GBMs, few studies so far have
reported on cardiovascular impacts after pulmonary exposure.
Following a single intratracheal instillation of GO (lateral
dimension: 2−3 μm, 2−3 layers, C/O ratio: 1.4) compared to
rGO (lateral dimension: 1−2 μm, 2−3 layers, C/O ratio: 8.5),
Bengtson et al. measured acute phase response proteins,
biomarkers for risk of cardiovascular disease.166 Unlike rGO,
GO sheets clearly induced a transient acute phase response, with
signiﬁcant increase of these biomarkers at day 1 and day 3,
disappearing by day 28 or day 90. In another study, increased
expression of the acute phase gene encoding SAA1 in the liver
was found after pharyngeal aspiration of graphite platelets.158
These limited results stress the need for further investigations
regarding the potential impact of GBMs on the cardiovascular
system after inhalation. In addition to these studies, there are
only a few studies on the interactions of GBMs with cells of the
cardiovascular system. For instance, myocardial H9c2 cells were
exposed to GO (lateral dimension: 380 nm, C/O ratio: 0.82) or
rGO (lateral dimension: 150 nm, C/O ratio: 1.70) in a recent
study.176 Cytotoxicity was dose-dependent above 10 μg/mL,
and rGO was found to be more toxic than GO and was inter-
nalized to a greater extent than GO. Singh et al. studied GO sheets
(lateral dimension: 0.2−5 μm) and noted strong activation and
aggregation of platelets with activation of Src kinases and release
of calcium from intracellular stores.177 Furthermore, intra-
venous injection of GO (250 μg/kg) was found to induce
extensive pulmonary thromboembolism in mice 15 min after
administration of thematerial. For comparison, reducedGOwas
signiﬁcantly less eﬀective in aggregating platelets in the lung
vasculature. The authors argued that variations in surface properties
may be responsible for the observed diﬀerences between the
twomaterials.177 However, they did not address the possible role of
the biocorona formed on GO or rGO, though it is likely that
both materials are “coronated” upon contact with blood.10
In contrast, GNPs functionalized with amine groups did not
activate isolated human platelets and did not induce pulmonary
thromboembolism in mice after i.v. administration.178 In addi-
tion, these amine-bearing GNPs did not cause hemolysis of
isolated human RBCs for concentrations as high as 10 μg/mL,
whereas GO sheets caused RBC membrane rupture even at the
lowest concentration (2 μg/mL).178
On the other hand, in biodistribution studies conducted in the
Graphene Flagship, no obvious acute cardiovascular or hemato-
logical adverse eﬀects were noted upon i.v. administration of
single- to few-layer GO sheets41,95 ormultilayeredGO inmice.40
Qu et al. reported that PBS-based and PBS-1%Tween 80-based
suspensions of GO did not cause thromboembolism in the lungs
of mice following i.v injection.89 Furthermore, GNPs and acid-
oxidized GNPs induced neither hemolysis nor activation and
aggregation of platelets.131 Following i.v. administration, PEG-
GO did not trigger hemotoxicity over a 3 month period.67
A recent study showed that whereas GO sheets caused hemo-
lysis, coating the GO sheets with lipid-based vesicles mitigated
this eﬀect.179
Overall, the lack of consistency between published studies
underlines the need to correlate biological eﬀects with physico-
chemical properties and suggests that further studies on the
potential impact of GBMs on the blood and cardiovascular
system are needed.
Gastrointestinal Eﬀects of Graphene-Based Materials.
The gastrointestinal (GI) system enables organisms to take in
food, digest it to extract and absorb nutrients and essential
elements, as well as expel the remaining waste as feces. There are
two major sources of potential oral exposure to nanomaterials:
(i) direct ingestion materials present in food or released from
food packaging and (ii) indirect ingestion of inhaled
materials.180,181 This means that oral ingestion is also relevant
in the occupational setting. Most of the inhaled nanomaterials
are trapped in the respiratory system and are transported upward
via the “mucociliary elevator” and ﬁnally swallowed down or
coughed out. Nanomaterials that enter the GI tract are
immediately exposed to saliva. Thereafter, they will be transported
into the stomach where they are exposed to its harsh conditions
(the pH of gastric acid whose main constituent is hydrochloric
acid is between 1.5 and 3.5) prior to being transferred into the
small and large intestines, where nutrients are resorbed out of the
bolus. Several factors such as digestive enzymes, pH, ionic
strength, surface-active compounds, and type and amount of
food intake have the potential to change the physicochemical
properties of nanomaterials, which has to be taken into account
in the hazard assessment of nanomaterials following the oral
exposure route.180 The small intestine with its villous structure
provides a large mucus-protected surface of around 2000m2, the
largest in the human body, enabling eﬃcient nutrient uptake.
The intestinal epithelium is composed mainly of enterocytes,
mucus-producing goblet cells, and so-called microfold cells
(M cells) important for the induction of an eﬃcient immune
response.182 The latter cells initiate mucosal immunity
responses on the apical membrane and allow for transport of
microbes and particles across the epithelial cell layer from
the gut lumen to the lamina propria, where interactions with
immune cells take place.183 The potential uptake and trans-
location routes of particles across the GI barrier could be either
paracellular or transcellular pathways. In addition to the cellular
barrier, the mucus lining of the GI tract forms an important and
eﬀective biological barrier against nanoparticle uptake and
translocation into the systemic circulation.184 It is important to
elucidate how GBMs interact with the GI system in comparison
to other particles in order to estimate the health risks of this class
of materials, but few studies are available to date.
One of the most commonly accepted in vitro intestinal models
in pharmaceutical and toxicological research consists of the
human colon adenocarcinoma cell line, Caco-2. This cell line
can be maintained as subconﬂuent cultures representing pre-
enterocytes. However, after 3 weeks of cultivation, the cells fully
diﬀerentiate to enterocytes, undergoing intense morphological
and physiological changes such as polarization, formation of
microvilli structures, and changes in gene and protein expression
compared to nondiﬀerentiated cells.185 Caco-2 cells have been
used in numerous studies to evaluate the potential impact of
nanoparticles on the GI tract.186−188 In recent years, more
advanced in vitro models have been developed such as 3D
cocultures,189 gut organoids or “mini-guts”,190 or gut-on-a-chip
models.191 However, there are few if any studies on the eﬀects of
GBMs using such models. Nevertheless, some recent studies
have addressed the potential toxicity of GBMs using the Caco-2
cell model (supporting Figure S5). Nguyen et al. exposedCaco-2
cells to GO ﬂakes at diﬀerent concentration (10−500 μg/mL)
and observed only mild cytotoxic eﬀects at higher concen-
trations.192 They speculated that the adsorption of medium
nutrients to the ﬂakes might be responsible for this observed
eﬀect. In a recent study conducted in the Graphene Flagship, the
uptake of GBMs was shown to be strongly dependent on the
diﬀerentiation state of the cells.81 Nondiﬀerentiated Caco-2 cells
were able to incorporate GO and GNP agglomerates of several
micrometers in size in a dose-dependent manner, whereas
diﬀerentiated Caco-2 cells displayed repellent properties toward
GBMs due to the presence of densely packed microvilli. This
suggests that the choice of in vitro models is crucial for the
outcome of the study. Ruiz et al. performed a test of the role of
GO-coated surfaces on mammalian cell attachment and
proliferation.193 To this end, control glass slides and glass slides
coated with GO produced by Hummers’ method were placed
onto a culture dish to which the colorectal adenocarcinoma
HT-29 cells were added. The results showed that GO ﬁlm
coated on glass slides enhanced cell attachment, growth, and
proliferation of these cells. In order to further elucidate the
inﬂuence of the physicochemical properties of GBMs on Caco-2
responses, Kucki et al. investigated a panel of GBMs (i.e., four
GOs and one GNP).194 The GOs diﬀered in the following
parameters: (i) size (from a few hundred nanometers to several
micrometers in lateral dimensions), (ii) starting material
(graphite versus graphite nanoﬁber), (iii) C/O ratio (around 2
for the GO samples and 24 for GNP), and (iv) number of layers
(thickness: 1 nm to 5 μm). The main outcome of this study was
that all four GOs were noncytotoxic toward nonconﬂuent Caco-2
cells, which are considered to be more sensitive than the
diﬀerentiated cells. Only relatively high concentrations (up to
80 μg/mL) induced a response. Pretreatment of the materials
with acid to mimic the conditions in the GI tract did not inﬂu-
ence the outcome. The GNP aggregates, on the other hand,
yielded a low level of acute toxicity at high concentrations, indi-
cating that aggregation, number of layers, or C/O ratio have a
more pronounced eﬀect on cell viability than the lateral dimen-
sions alone.194 In another related study, treatment of GO and
FLG with digestive juices to simulate oral ingestion did not
induce structural changes/degradation of the materials, and
chronic exposure to the digested GBMs did not aﬀect the intes-
tinal Caco-2 barrier despite long-term exposure (1 and 5 μg/mL;
2 h every 2 days up to 9 days).195
The microbiome is considered to be our “forgotten organ,”
and the gut microbiota is involved in the regulation of multiple
metabolic, signaling, and immune-inﬂammatory pathways in the
host that physiologically connect the gut, liver, muscle, and
brain.196 In a recent in vivo study, GO was found to exert milder
eﬀects following oral exposure when compared to single-walled
carbon nanotubes (SWCNTs) and multiwalled carbon nano-
tubes (MWCNTs).197 Importantly, the authors also investigated
whether these carbon-based nanomaterials had any impact on the
gut microbiome by assessing the impact on gut microbiota
composition using 16S rRNA gene sequencing approaches.
Analysis of the microbiota at various taxonomic levels showed
marked changes of diversity and composition of gut microbiota
after acute oral administration of SWCNTs, MWCNTs, and
GO. The 16S rRNA gene sequencing results showed signiﬁcant
shifts of the predominant microbe phyla from Firmicutes to
Bacteroidetes in SWCNT-treated mice, and exposure to
MWCNTs yielded similar alterations as noted for SWCNTs at
both phyla and genus levels.197 However, compared to the oral
exposure to SWCNTs andMWCNTs, the exposure toGO showed
a more pronounced impact on the gut microbiota (Figure 5).
In conclusion, the ﬁrst explorative studies in this relatively
new ﬁeld have shown no or only mild acute cytotoxicity of
several diﬀerent GBMs on intestinal epithelial cells. However,
the ﬁeld is in its infancy, and aspects of long-term eﬀects of
GBMs including the inﬂuence on the microbiota remain
unanswered today. Therefore, further studies are needed to
understand the potential impact of diﬀerent GBMs following
oral exposure.
Reproductive and Developmental Eﬀects of Graphene-
Based Materials. Pregnant women, fetuses, and neonates are
among the most vulnerable populations and therefore warrant
particular attention in regard to GBM hazard assessment.
In pregnancy, major physiological changes occur that are
expected to aﬀect particokinetics and subsequent biological
eﬀects. Likewise, developing fetuses and neonates are more sus-
ceptible to toxic eﬀects of xenobiotics than adults due to ongoing
organogenesis, physiological changes, or immaturity of the
immune system. To date, it is unknown whether GBMs can
reach the placental barrier or reproductive organs. The low
transfer of nanoparticles at the air−lung, skin, and intestinal
barrier198 and the rapid clearance of GBMs from the
bloodstream (discussed above) would argue for a low acute
exposure under currently prevailing inhalation and oral exposure
scenarios. However, emerging biomedical applications of GBMs
and the possibility of tissue accumulation upon chronic exposure
of these materials clearly suggests that close attention is needed
to the potential reproductive and developmental risks of GBMs.
First indications that nanoparticles may interfere with
pregnancy and fetal health came from epidemiological studies
showing that maternal exposure to air pollution (in particular, to
particulate matter <2.5 μm) during pregnancy was associated
with adverse birth outcomes such as low birth weight and
preterm birth (reviewed in ref 199). As a consequence, research
on the placental transfer of nanoparticles and the impact on
reproductive and developmental systems was intensiﬁed. For
carbonaceous nanomaterials including carbon nanotubes, the
ﬁndings suggest that these materials may, indeed, have the
potential to adversely aﬀect pregnancy and embryonic/fetal
development.200 However, for GBMs, the existing literature is
still too limited, and results are too conﬂicting to draw ﬁrm
conclusions regarding their potential reproductive and devel-
opmental risks. Male fertility and reproduction was not aﬀected
after intravenous and intraperitoneal injection of small or large
GO in mice201 nor by pulmonary exposure to GO.202 Moreover,
no damage to testis tissue was apparent in male mice after intra-
venous injection of GO,89 FLG, oxidized FLG, or PEGylated
FLG.93 In addition, pre- or postfertilization injection of single-
or few-layer small (20−150 nm) and large (200−1500 nm) rGO
did not alter sex hormone levels in female mice.203 However, in
the latter study, the authors observed that when small rGO was
injected in late gestation, this resulted in abortions, malformed
fetuses, and death of pregnant mice. Thus, based on these
observations, the toxicity of rGO should be seriously considered
in progestational (drawing near pregnancy) females, although
the rGO-exposed mice could still produce healthy oﬀspring
depending on the administered dose.203 Developmental toxicity
of GBMs has also been described in other species including
zebraﬁsh and chicken,204,205 but because these models lack a
mammalian maternal−placental−embryonic/fetal relationship,
their predictive value for human developmental and reproduc-
tive toxicity assessment is limited.
The placenta forms the interface between mother and fetus
and enables successful pregnancy by mediating essential func-
tions including exchange of gases, nutrients, and waste products,
hormone secretion, feto-maternal immune tolerance, and fetal
protection against pathogens and xenobiotics. Therefore, it is
critical to understand placental translocation and eﬀects of
GBMs in order to estimate their embryo fetotoxic risks. How-
ever, it is currently unclear if and by which pathway(s) GBMs
may pass the placental barrier at diﬀerent stages of pregnancy.
A single study investigating transplacental transfer of 125I-rGO
after intravenous injection in pregnant mice in late gestation
measured only trace amounts of radioactivity in the placental or
fetal tissues (approximately 0.3% of the applied dose), which
may also have resulted from transfer of free 125I.205 Nevertheless,
placental translocation has been described for diﬀerent nano-
particles throughout pregnancy including carbonaceous materi-
als such as MWCNTs.206−208 Interestingly, embryo fetotoxic
eﬀects of carbon nanomaterials were not necessarily correlated
with placental transfer of nanoparticles (direct eﬀects) but may
result from adverse eﬀects of particles on maternal and placental
tissue (indirect eﬀects).209,210 For small rGO, malformed fetuses
and abortions were found after injection during late gestation
without apparent particle translocation.205 The authors sug-
gested that adverse eﬀects elicited by small rGO in the maternal
mice (e.g., decrease of white blood cell number) may indirectly
account for the observed developmental toxicity. Another exam-
ple of a maternally mediated eﬀect was a reduced growth of the
oﬀspring when maternal mice were given GO-containing
drinking water (0.5 mg/mL).211 Potential placenta-mediated
eﬀects of GBMs, e.g., interference with placental viability and
functionality, have not been extensively explored. However, in a
recent study in the Graphene Flagship, the impact of four GO
samples on human BeWo trophoblast cells did not reveal overt
cytotoxicity after 48 h of exposure at concentrations up to 40 μg/mL
despite internalization of the GO sheets.212 On the other hand,
exposure to GO induced a transient opening of the trophoblast
barrier as evidenced by a temporary increase in the translocation
of sodium ﬂuorescein and a slight decrease in human chorio-
gonadotropin secretion.212 These observations underscore the
need for further studies on the long-term consequences of
GBMs on placenta functionality and maternal−fetal health. It is
pertinent to note that rGO has been suggested to induce a
transitory decrease in the tightness of the blood−brain barrier in
rats; rGO was systemically injected in the latter study, and the
relatively large size (average size: 342 nm) of the material was
apparently not an obstacle for its entry into the brain.213 Overall,
a better understanding of potential interferences of GBMs with
placental, reproductive, and developmental functions will be
Figure 5. Carbon-based nanomaterials and the gut microbiome. Comparison of bacterial community abundance at phylum level after acute oral
administration of SWCNTs, MWCNTs, and GO to mice (2.5 mg/kg for 7 days). The pie charts show the relative abundance of gut microbiota
based on 16S rRNA gene sequencing. Reprinted with permission from ref 197. Copyright 2018 Wiley-VCH Verlag GmbH & Co.
imperative for the sustainable and safe use of GBMs, not least as
reproductive and developmental toxicity has been reported for
other carbon-based nanomaterials.209,214 For studies on pla-
cental translocation and eﬀects of GBMs, human models (e.g.,
ex vivo placenta perfusion, placental explant cultures, or pla-
cental microtissues) are available to complement in vivo studies
and to avoid uncertainties in the extrapolation of results due to
species-speciﬁc diﬀerences in placental structure and function.215
Finally, in addition to direct eﬀects of GBMs on reproductive
and developmental systems, the indirect consequences of GBMs
on maternal and placental tissues and the release of mediators
deserves attention as the creation of a hostile environment in the
wombmay increase the risk for pregnancy complications and the
development of diseases later in life.
Central Nervous System Eﬀects of Graphene-Based
Materials. Graphene holds exciting prospects in neuroscience;
the unique physicochemical properties, such as the high con-
ductivity, transparency, or ﬂexibility, make this material an attrac-
tive candidate to engineer functional brain implants with excellent
performance for neuromodulation therapies or to design scaﬀolds
able to support the reconstruction of functional neurons and glial
cells networks, also an imperative requirement for neural regen-
eration of central nervous system (CNS) injuries.216 Particularly
relevant in neurology is the on-demand release of drugs enabling
precise targeted dosing to meet the requirements of diverse
therapeutic applications. Naturally, the implementation of multi-
functional neurodevices based on graphene will expose brain cells
and neuronal circuits directly to this material by injection or
implantation, and safety assessment of graphene and its derivatives
is therefore of paramount importance. In the following sections,
we will discuss interactions of GBMs with the CNS.
Studies conducted in the Graphene Flagship have disclosed
that GBMs are able to interact with and perturb cells of theCNS in
diﬀerent ways, as a function of their intrinsic characteristics.217,218
Hence, investigations exploring the responses of brain cells to
prolonged GO exposure, pointed out a clear lateral size-related
cytotoxicity.217 The eﬀect of GO ﬂakes of diﬀering lateral
dimensions was evaluated on cells belonging to relevant struc-
tures of the CNS, maintained in culture. Neurons and glial cells
from dissociated rat hippocampus or cortex were cultured in the
presence of 10 μg/mL dispersions of large and small GO.217
After 6−8 days of incubation, it appears that large, micrometer-
sized ﬂakes of GO induced unequivocal neuroglial and neuronal
loss. Interestingly, when cells were treated with the same con-
centration of FLG, no reduction in cell density or viability was
observed in both neuronal and glial populations, thus demon-
strating that CNS cells survival in vitro seems crucially depen-
dent on the graphene sheet dimensions as well as its chemical
composition.217 However, even in the absence of cytotoxicity,
we cannot rule out other potential eﬀects on neuronal or glial
function brought about by the exposure to GBMs.217 In these
experiments, patch clamp recordings and ﬂuorescence imaging
were used to check the ability of FLG and GO nanosheets
(about 100 nm in lateral dimensions) to interfere with synaptic
signaling when cells were exposed for 1 week to a growth
medium containing such materials at 1 or 10 μg/mL concen-
trations. Passive cell properties, neuronal network organization,
and overall network activity of neurons interfaced with FLG at
both concentrations did not diﬀer from control hippocampal
cells. Instead, small GO ﬂakes interfered speciﬁcally with
neuronal synapses, albeit without aﬀecting cell viability.217
In particular, while at the lower concentration of GO, network
synaptic activity was not altered, a signiﬁcant reduction in
postsynaptic current frequency was detected at 10 μg/mL. Thus,
GO nanoﬂakes at higher concentrations seem able to speciﬁcally
downregulate synaptic activity. The results also showed that GO
nanoﬂakes only impaired excitatory (glutamate AMPA receptor-
mediated) synapses, whereas they did not impair inhibitory
GABAA-mediated connections.
217 The authors proposed that
the selective interference of GO with the excitatory presynaptic
terminals versus the inhibitory GABAergic terminals could be
due to the diﬀerent dimensions of the excitatory and inhibitory
synaptic clefts.219 On the other hand, the diﬀerent behavior of
FLG of matching dimensions could be explained by their
hydrophobic surface resulting in a modest ability to interact with
the plasma membrane as the formation of aggregates in the cell
culture are not suited to interface with submicroscopic struc-
tures such as synapses in the brain.
Studies were also conducted to test the ability of nanosized
FLG and GO to reduce exocytosis and recycling of synaptic-like
microvesicles from cultured primary glial cells.217 Microvesicles
are released into the extracellular space by direct budding from
the plasma membrane of astrocytes and have been shown to
have an important role in intercellular communication.220 Pure
glial cell cultures were treated with FLG and GO suspensions
(10 μg/mL) for 6−8 days. FLG and GO did not aﬀect astrocyte
density, excluding a cytotoxic eﬀect. It is well-known that micro-
vesicle release could be artiﬁcially induced in glial cells cultures
by 2′,3′-[benzoyl-4-benzoyl]-ATP (BzATP) and subsequently
detected and quantiﬁed by immunoblot analysis of the collected
supernatant.221 Surprisingly, the treatment of astrocytes with
GO resulted in an eﬀect similar to BzATP stimulation inducing
pronounced vesicle release. Intriguingly, similar experiments
with FLG at the same concentration and duration did not induce
shedding of microvesicles in glial cell cultures. Summarizing the
results obtained thus far, one can conclude that while the lateral
size of graphene ﬂakes is critical in deﬁningmaterial cytotoxicity,
the oxidative state also plays a role and may explain the diﬀer-
ence between a neutral eﬀect of FLG versus the ability of GO to
perturb innate vesicular regulation mechanisms presumably
via plasma membrane interactions.
The physical interaction of GBMs with the plasma membrane
is strongly aﬀected by the physicochemical properties of the
material. Recent studies showed that FLG and GO nanosheets
were internalized by neurons mainly through the endosomal/
lysosomal pathway; moreover, electron microscopy analysis
revealed a number of particles free in the cytoplasm, which had
either pierced the membrane or escaped from intracellular
organelles (Figure 6).218 Of note, no particles were observed
inside the nucleus, either in neurons or in astrocytes, thus
making it unlikely for any direct genotoxic damage to occur.218
The amount of internalizedmaterial (FLG andGO)was relatively
low for neurons and never exceeded 15% of the total amount of
material present in the cell culture, whereas astrocytes and
microglia internalized up to 30−40% of the administered ﬂakes,
coherent with their primary function in defending neurons from
insults.218 Furthermore, whereas nanosheet-exposed neurons
formed a well interconnected network, astrocytes displayed
marked morphological alterations, reminiscent of activated/
mature glia, and similar to those changes induced by carbon
nanotubes.222 Such morphological changes are likely due to
nanomaterial interactions with and disruption of the cellular
actin cytoskeleton.223,224
Furthermore, and in contrast to the aforementioned studies in
which cells were exposed to nano- or micron-sized ﬂakes, studies
on surface-immobilized GBMs have also been reported. Tu et al.
systematically modiﬁed the properties of GO by attaching dif-
ferent functional groups and found that by manipulating the
charge carried by the functionalized GO, the outgrowth and
branching of neuronal processes could be controlled.225 Thus,
compared with neutral, zwitterionic, or negatively charged GO,
positively charged GOwas found to be more beneﬁcial for neurite
outgrowth and branching in a model of primary rat hippo-
campal neurons grown on GO-coated glass slides. Recent studies
from the Graphene Flagship focused on surface-immobilized
graphene produced by liquid phase exfoliation or ball-milling of
graphite and showed that such substrates are inert neuron-
interfacing materials, able to preserve the basal physiological
level of neuronal activity.226 Hence, graphene-based substrates
were successfully used to support the development of primary
neurons from rat hippocampus. In a related study, changes in
membrane cholesterol were noted in hippocampal neurons
grown on graphene-coated surfaces, resulting in a presynaptic
potentiation of neurotransmission.227 More recently, another
study from the Graphene Flagship showed that single-layer
graphene increases neuronal ﬁring of rat hippocampal neurons
by tuning the distribution of extracellular ions at the neuron−
graphene interface (Figure 7).228 This work hypothesizes, on the
basis of experimental and theoretical approaches, that this is due
to the interactions between graphene and cations, in particular,
potassium, that are maximized when graphene is deposited on
electrically insulating substrates.228 The possibility arises to exploit
such substrates as next generation brain interfaces. In this context,
the uncommon ability of surfaces decorated by immobilized
graphene to support neuronal development (in terms of neuronal
passive properties, spontaneous synaptic activity, synaptogene-
sis, and short-term synaptic plasticity) without precoating with
adhesion-promoting peptides (e.g., polylysine or polyornithine)
deserves to be highlighted. Previous work demonstrated the
biocompatibility of peptide-coated chemical vapor deposited
graphene interfaces with hippocampal neurons (polylysine-
coated graphene)229 or neural stem cells (laminin-coated graph-
ene).230 However, peptide coating might weaken neuron/
interface electrical contacts and electrical signal transmission,
resulting in non-optimal charge transfer.231,232 Surface immobi-
lization of graphene seems to prevent toxic eﬀects and could be
Figure 6. Graphene interactions with neurons. Primary rat cortical neurons were exposed to FLG (here abbreviated GR) and GO ﬂakes (1 and
10 μg/mL) for 96 h or 14 days or to equivalent volumes of the respective vehicles. SEMwas used to study the interaction of ﬂakes with neuronal
cells. (e−h) Large number of ﬂakes (white arrowheads) were found in contact with the cell membrane; however, cell morphology and network
development were largely unaﬀected. (i−l) Cell uptake of FLG and GO and intracellular localization were studied by TEM. At 24 h, most of the
ﬂakes were found outside the cells (not shown). However, starting from 96 h, ﬂakes were internalized into intracellular vesicles (i,j; black
arrowheads) or free in the cytoplasm (l; black arrowheads). Reprinted from ref 218. Copyright 2016 American Chemical Society.
exploited to promote neuronal development. However, more
studies are needed to evaluate the long-term integrity of such
substrates. Furthermore, although studies on explanted neurons
are informative, detailed in vivo studies on the inﬂuence of
graphene on neuronal microcircuits are lacking.
For a comprehensive view of the impact of GBMs on the
brain, it is important to address not only eﬀects on neurons but
also eﬀects on non-neuronal cells, i.e., glial cells including astro-
cytes and microglia. To better understand the molecular and
cellular processes aﬀected by the exposure to GBMs, proteomic
and lipidomic analyses were conducted on primary neuron and
astrocyte cultures exposed to GO and, in the case of astrocytes,
to GO or FLG.218 Among the common pathways aﬀected in
both neurons and glial cells, we ﬁnd Ca2+ signaling, of vital
importance in almost every aspect of neural cell physiology, with
several Ca2+-binding and buﬀering proteins being markedly
up- or downregulated in exposed cultures, along with intracellu-
lar traﬃcking, which likely mediates the observed endocytotic
and/or phagocytic responses.218 The lipidomics analysis
revealed that the exposed neurons were characterized by an
upregulation of phosphatidylethanolamine and downregulation
of phosphatidylserine. PE is one of the major components of the
plasma membrane and synaptic vesicle membrane and plays
important roles in vesicle fusion and ﬁssion.233 Cholesterol was
found to be one of the most altered lipids in astrocytes exposed to
the nanosheets.218 Cholesterol is a structural component of lipid
rafts, which mediate the signaling between endoplasmic reticu-
lum and plasma membrane in astroglial cells.234 Regarding the
functionality of nanosheet-exposed cultures, a closer analysis of
Ca2+ dynamics revealed marked alterations in both neurons and
astrocytes consisting of reduced number of spontaneously oscil-
lating cells, reduced basal cytoplasmic Ca2+ concentration, and
altered responses to external stimuli. Interestingly, these eﬀects
were elicited only by chronic GO exposure, whereas acute
exposure to FLG and GO did not cause any functional altera-
tions in both culture systems. For astrocytes, recent studies
showed that a marked alteration of K+ currents was selectively
triggered by GO.235 More speciﬁcally, an increase in outward
rectifying currents was observed, together with a hyperpolarized
membrane potential, decreased input resistance, and increased
speciﬁc conductance. Interestingly, a signiﬁcant increase in
astrocyte-released microvesicles was also observed in cell
cultures treated with GO.217 Ca2+ dynamics, glutamate uptake,
and microvesicle release are all fundamental processes in the
astrocyte-to-neuron communication. To conclude, in vitro studies
on primary neurons and glial cells show that, while chronic
Figure 7. Graphene modulation of neuronal communication. (Top row) AFM topography reconstructions of glass control, single-layer
graphene (SLG), multilayer graphene (MLG), and gold-plated glass surfaces. AFM documented a surface roughness of thematerials that varied
from 0.23± 0.02 nm for the control (n = 3), 1.5± 0.5 nm for SLG (n = 3), 20± 10 nm forMLG (n = 3), and 0.47± 0.1 nm for Au (n = 3). Scale
bar, 5 μm. (Middle row) Representative SEM images depicting hippocampal neuron morphology after 10 days in vitro, supported by the
diﬀerent substrates. Culture substrates were not pretreated with additional adhesion molecules that might mask the eﬀects of graphene. Scale
bar, 10 μm. (Bottom row) SLG triggers changes in single-cell intrinsic excitability. Representative current-clamp recordings of hippocampal
neurons in culture for 10 days. Control and SLG neurons displayed similar resting membrane potentials (−52± 10 mV in SLG;−50± 7 mV in
control).Whenmaintained at−60 mV, the spontaneous action potential ﬁring wasmeasured as summarized in the histograms (right). Note the
signiﬁcantly higher action potential frequency in SLG (2.60± 0.36 Hz in neurons grown on SLG, n = 21; 1.37± 0.26 Hz in control, n = 19; P =
0.0054). *P < 0.05, **P < 0.01. Reprinted with permission from ref 228. Copyright 2018 Nature Publishing Group.
exposure to FLG or GO does not cause cell death, it has a strong
impact on a number of fundamental physiological processes,
thus potentially leading to toxicity when administered for pro-
longed amounts of time. In fact, studies performed in the
Graphene Flagship have revealed a size-dependent toxicity of
graphene toward neurons and glial cells. However, some char-
acteristics of FLG could potentially be harnessed to restore
pathological alterations in the CNS. Thus, future studies should
address the possibility of functionalizing GBMs to exploit
selected features while tuning properties that could potentially
lead to unwanted eﬀects.
ENVIRONMENTAL HAZARD ASSESSMENT OF
GRAPHENE-BASED MATERIALS
The tremendous advancement in the ﬁeld of nanotechnology
has been accompanied by a slower progress in the understanding
of its impact on the environment. Large-scale production, leach-
ing out of from enriched products, accidental spills during indus-
trial production, and poor disposal of the derived wastes might
result in signiﬁcant release and accumulation of GBMs in the
environment. This phenomenon already occurred for other
synthetic materials such as plastics that were hailed as the “discovery
of the century” by their inventors and producers and correctly
predicted to change the everyday lives of people. However, although
the promises were fulﬁlled, the beneﬁts were unfortunately
counterbalanced by unexpected environmental problems, which
emerged in dramatic fashion only half a century later.236 Hence,
exploring the ecotoxicity of GBMs is of fundamental impor-
tance.237 To this end, a wide range of organisms has been inves-
tigated, not least in the Graphene Flagship, including bacteria,
algae, seed plants, invertebrates, and vertebrates in a variety of
ecosystems.
Eﬀects of Graphene-Based Materials on Bacteria.
Studying the eﬀects of carbon-based nanomaterials on bacteria
is essential as they are at the basis of the trophic chains in the
environment, involved in many stages of the nutrient cycles, and
have complex associations with other organisms. Eﬀects of
GBMs on bacteria are rather well-studied, compared to other
living systems. The most commonly used laboratory model is
Escherichia coli. Several studies have shown that direct contact
between GBM and bacteria is responsible for the observed
toxicity toward E. coli and other bacteria.238−244 Liu et al.
described the antibacterial activity of four types of GBMs
(graphite, graphite oxide, GO, and rGO) toward E. coli. GO
dispersions exhibited the highest antibacterial activity, followed
by rGO, graphite, and graphite oxide.238 Dizaj et al. reported that
the physical interaction between microorganisms and carbon-
based nanomaterials (carbon nanotubes, GO, and fullerene)
aﬀected cellular membrane integrity, metabolic processes, and
morphology of microorganisms.239 Using experimental and
theoretical (modeling) approaches, Tu et al. suggested that
graphene and GO nanosheets can induce the degradation of the
inner and outer cell membranes of E. coli, thereby reducing their
viability.245 In a more recent study designed to address the role
of functional groups, Li et al. utilized reduction and hydration
methods to establish a GO library with diﬀerent oxidation,
hydroxyl, and carbon radical (C●) levels to study the impact on
antibacterial activity.246 Using antibiotic-resistant bacteria, the
authors could show hydrated GO, with the highest C● density,
had the strongest antibacterial eﬀects through membrane bind-
ing and induction of lipid peroxidation, suggesting that C● is the
principle source that can be utilized for clinical applications of
GO-based antibacterial coatings, e.g., catheters. On the other
hand, Ruiz et al. reported that GO-coated surfaces could pro-
mote proliferation of E. coli with the formation of dense bio-
ﬁlms.193 Furthermore, Guo et al. observed that GO signiﬁcantly
enhanced the cell growth, bioﬁlm formation, and bioﬁlm
development for E. coli and Staphylococcus aureus, whereas
rGO strongly inhibited cell growth and bioﬁlm formation.243
To investigate the orientation-dependent interaction of GBMs
with bacteria, Lu et al. aligned GO nanosheets in a magnetic
ﬁeld, immobilized by cross-linking of the surrounding matrix,
and exposed on the surface through oxidative etching.247 The
GO nanosheets with vertical orientation exhibited enhanced
antibacterial activity toward E. coli compared with random and
horizontal orientations of GO. The authors proposed that the
antibacterial mechanism requires penetration of the cell
membrane, suggesting that the enhanced antibacterial activity
of the ﬁlm with vertically aligned GO is due to an increased
density of edges with an orientation that is more compatible with
membrane disruption.247 In another recent study, graphene
ﬂakes grown perpendicularly to the surface exhibited a strong
inhibitory eﬀect on the adhesion of bioﬁlms of E. coli and
S. epidermidis, causative agents of urinary tract infections and
infections related to implants and catheters.248 The authors also
reported that this graphene-based “bed-of-nails” did not impart
any cytotoxicity toward murine ﬁbroblasts or human neuro-
blastoma cells. Thus, the properties of GBMs as well as their
orientation and the degree of membrane interactions control
their antibacterial eﬀects.
Eﬀects of Graphene-Based Materials on Photoauto-
trophs. Recently, the ecotoxicity of GBMs was evaluated on
various model and nonmodel photoautotrophs, from cyanobac-
teria to seed plants. These organisms are all characterized by the
presence of a cell wall of diﬀerent composition and ultrastructure
(peptidoglycans in cyanobacteria, cellulose in algae, and embryo-
phytes), often completed by further external structures (in cyano-
bacteria, an outer lipopolysaccharidic membrane, a capsule, and a
gelatinous sheath; in many algae, a layer of exopolymeric
substances). The cell wall is a physical barrier that retards the
entrance of GBMs larger than the pore size of the cell wall.249
Moreover, the interaction could diﬀer not only among orga-
nisms but also with the age of the organism. In the cells of seed
plants, for instance, thickness and complexity of cell wall change
drastically from the pectic-rich primary wall, generally a thin,
ﬂexible, and extensible layer formed when the cell is growing, to
the thick secondary wall, formed after the cell is fully grown, made
of cellulose, xylan, and lignin, which strengthens and water-
proofs the wall. Observations on GBM internalization carried out
on cell cultures in active division can thus produce divergent
results in comparison to studies based on adult tissues or organs.
Not surprisingly, internalization has been repeatedly reported in
tobacco cell cultures and in a few thin-walled green algae, such as
Chlorella pyrenoidosa and C. vulgaris, but could not be conﬁrmed
in the thick-walled green alga, Trebouxia gelatinosa (see below).
Despite their considerable ecological importance, cyanobac-
teria have rarely been studied in relation to ecotoxicology of
GBMs. The freshwaterMicrocystis aeruginosawas investigated by
Tang et al., who tested combined exposures to GO and Cd2+
(concentrations between 1−50 μg/mL and 0.2−0.7 μg/mL,
respectively).250 The authors observed that GO alone at low
concentrations had no signiﬁcant toxicity, even if the material
easily adhered to and entered into the algal cells. However,
mortality and induction of oxidative stress due to Cd2+ uptake
were both increased by the presence of GO. Furthermore, the
antibacterial properties of GO (from 85 μg/mL to 1 mg/mL)
toward strains of two epilithic cyanobacteria,Oculatella subterranea
and Scytonema julianum, isolated from Roman catacombs, seemed
to inhibit in vitro bioﬁlm growth, and for this reason, it is suggested
that GO could be suitable for the restoration of stone artifacts.251
Microalgae are highly ecologically relevant as primary producers
as they are also at the base of the trophic food chain in aquatic
ecosystems. The toxicity of carbon-based nanomaterials in algae is
mainly due to interactions with the cell surface but is also due to
other factors, including shading (reducing their photosynthetic
activity), oxidative stress, or sequestration of nutrients.252
Exposure of Scenedesmus obliquus to rGO for 72 h suppressed
growth and inhibited chlorophyll a and chlorophyll b levels,
apparently due to increased oxidative stress.253 rGO signiﬁcantly
downregulated photosystem II activity due to the coating of the
rGO on the algal cell surface. GO, rGO, andmultilayer graphene
(MLG) exhibited much higher toxicity than other carbonacous
materials (i.e., carbon nanotubes and graphite) to Chlorella
pyrenoidosa.254 The shading eﬀect was incriminated in the
growth inhibition by GO due to its higher dispersibility and
transformation, whereas the other GBMs did not show such
eﬀects. It can be questioned whether the decrease of light reachi-
ng the photosystems due to the formation of algal-nanocarbon
aggregates255−257 is suﬃcient evidence of GBM toxicity, as
microalgae can typically optimize their photosystems to the light
environment through photoacclimation.258 Therefore, some
variations in the growth rates reported in the literature might be
the result of observation times incompatible with photoacclima-
tion phenomena. In a recent publication from the Graphene
Flagship using the aquatic benthic diatom Nitzschia palea, it has
been shown thatMLG is able to induce growth inhibition only in
the ﬁrst hours of contamination.259 These results could be
explained by direct contact with the diatoms and to the shading
eﬀect. However, the extracellular polymeric substances (EPS)
mainly composed of polysaccharides and proteins naturally
secreted by diatomsshowed a strong interaction with graph-
ene, leading to growth recovery after trapping of the EPS.259 The
latter study implies that the presence of an “eco-corona” may
impact on the ecotoxicity of GBMs in analogy with the presence
of a biocorona in the human body.
More recently, aeroterrestrial green microalgae (AGMs) were
also studied in relation to GBMs. AGMs are a small group of
polyphyletic origin, with a relatively low substrate speciﬁcity and
with a strong tendency to be cosmopolitan.260 AGMs are able to
survive high UV radiation, temperature extremes, and prolonged
periods without liquid water in the desiccated state (desiccation-
tolerant species),261 and some enter into symbiotic relationship
with fungi (lichenization). These species were not negatively
aﬀected by short (30 and 60 min) and long (4 weeks) exposures
to FLG and GO. Potential oxidative eﬀects of the same GBMs
were also studied through the analysis of quantum yield of
primary photochemistry in the dark-adapted state and changes
of gene expression of eight genes encoding antioxidant enzymes
and stress-related proteins in the lichen photobiont Trebouxia
gelatinosa.262 Interestingly, GO was found to be inert, and FLG
caused the downregulation of a single gene (HSP70), although
this did not correspond to a decrease in the expression of HSP70
protein. These studies suggest a negligible eﬀect of GBMs on
AGMs which likely can withstand the interaction with these
materials thanks to their constitutive adaptation to extreme envi-
ronments and the avoidance of internalization of GBMs as a
result (in Trebouxia) of a thick cell wall.
Eﬀects of Graphene-Based Materials on Seed Plants.
As primary producers, seed plants are essential base components
of all terrestrial ecosystems. Under the assumption that aero-
dispersed GBMs will eventually settle over the vegetation as wet
or dry depositions and thus will reach the soil,263 seed plants are
considered as potent media for the transfer of absorbed nano-
materials to the biota through the food chain. For this reason,
the eﬀects of GBMs on seed plants have been studied at diﬀerent
growth stages, from seed to seedling, more rarely in the adult
plant, but often starting from cell cultures. So far, widely variable
eﬀects have been reported, possibly owing to diﬀerent experi-
mental conditions (i.e., materials, concentrations, exposure time,
protocols, etc.) and/or species tested. Using cell suspensions of
the model plant, Arabidopsis thaliana exposed to a poorly char-
acterized “graphene” (most probably GO), negative eﬀects in
terms of nuclear fragmentation, membrane damage, mitochon-
drial dysfunction, and ROS production and accumulation were
noted, leading to induction of cell death.264 Instead, no eﬀects
were observed on seed germination or development of seed
sprouting. In 2 week old seedlings of A. thaliana cultured with
GO for 2 further weeks, it was observed that the material accu-
mulated in the root system but not in the leaf cells, implying that
the plant copes with GO translocation from root to stem or
leaves, although GO was found in all the compartments of the
cotyledon cells.265,266 Further studies have revealed more pro-
blematic eﬀects on seed germination and seedling growth.
Hence, although methodological problems cannot be ruled out
due to the low number of samples, germination inhibition has
been reported for wheat (Triticum aestivum) and broad bean
(Vicia faba) when exposed to graphene and GO. In wheat, GO
inhibited the germination of seeds at high concentrations and
was observed to accumulate in the root, with a limited trans-
location to stem and leaves, inducing oxidative stress.267 In rice
seed, delayed germination rates were observed with increasing
graphene concentrations (50 μg/mL and above), and the
growth of radicle and plumule was inhibited.268 Notably, graph-
ene at a concentration of 5 μg/mL improved some growth indexes.
Indeed, carbon-based nanomaterials may have beneﬁcial eﬀects
in plants, although the mechanisms remain poorly understood.
For example, the absorption of GO by the roots in Vicia fabawas
found to have both beneﬁcial and toxic eﬀects depending on the
concentration.269 Increased V. faba sensitivity at the highest
doses was apparently due to an increased oxidative stress and a
concomitant impairment of glutathione metabolism, whereas
lower concentrations showed positive eﬀects. In spite of their
protective cell walls, harmful eﬀects of carbon-based nanoma-
terials have also been reported in adult seed plants (reviewed in
ref 270). For instance, the leaves of cabbage, spinach, and
tomato exhibited a decrease in size after in vivo exposure to GO
and a decrease in number due to oxidative-stress-mediated cell
death by necrosis.271
Aero-dispersed GBMs could interfere with a particularly
delicate phase of seed plant life, i.e., fecundation. This process is
fundamental for the reproduction of almost all seed plants, but it
is also important for humankind as the yield of crop species,
largely consisting in seed and fruits, relies on this very important
process. The interaction between GBMs and pollen grains might
occur directly in the air (anemophilous pollen) or over the stig-
matic surfaces of the ﬂowers (all pollen types). Recent in vitro
experiments onpollen performance in themodel speciesNicotiana
tabacum and in the nonmodelCorylus avellana showed that pollen
germination and tube elongation were aﬀected at GO concen-
trations ≥50 μg/mL, decreasing by 20 and 19% in N. tabacum
and by 68 and 58% in C. avellana, respectively.272 The frequency
of bended tubes increased in N. tabacum. Ratiometric pH
indicator studies revealed that GO aﬀects intracellular pH
homeostasis. Further experiments on C. avellana demonstrated
that themain factor inﬂuencing pollen performances is the acidic
property of GO. FLG also showed a minimal negative eﬀect on
pollen tube elongation, probably due to physical interactions with
the pectin-rich wall of the pollen tube and/or Ca2+ sequestration,
whereas pollen germination and pollen tube growth were not
aﬀected by rGO.272
Eﬀects of Graphene-BasedMaterials on Invertebrates.
Aquatic and terrestrial invertebrates are likely to be exposed to
carbon-based nanomaterials as they accumulate in the terrestrial/
sedimentary compartment. For terrestrial eﬀects, most studies are
carried out with worms, especially the nematode Caenorhabditis
elegans, a model system that is amenable to mechanistic studies.
Zhang et al. studied nanosized GO and GO modiﬁed with
PEGylated poly-L-lysine using C. elegans and proposed a mecha-
nism of toxicity under stress conditions involving the over-
production of hydroxyl radicals and the formation of oxidizing
cytochrome c intermediates.273 Furthermore, in a high-through-
put study encompassing 20 diﬀerent nanomaterials, GO was
found to be the most toxic toward C. elegans among the carbon-
based nanomaterials, followed by rGO and graphene.274 Zhao
et al. reported that nanosized GO triggered reproductive toxicity
with germ cell apoptosis.275 Notably, the authors identiﬁed an
epigenetic, miRNA-based regulatory mechanism activated by
GO to suppress the induced reproductive toxicity. The same
authors suggested that mir-231 may provide a protective
mechanism against toxicity of GO by suppressing the function
of the SMK-1-DAF-16 signaling in nematodes.276 Ren et al.
showed activation of a series of antimicrobial proteins in the
nematode after exposure to GO.277 In contrast, graphite nano-
platelets did not aﬀect longevity and reproductive capability in
C. elegans.278 The authors deployed FTIR for mapping the
spatial distribution of this material in nematodes. In the insect,
Acheta domesticus, commonly known as the house cricket, oxida-
tive stress was observed after injection of pure and manganese-
contaminated GO into the hemolymph, a tissue/ﬂuid similar to
blood in vertebrates.279
In the aquatic environment, pelagic species living in the water
column and benthic species living near or within the sediment
could be naturally impacted by the presence of carbon-based
nanomaterials, depending on their bioavailability to pelagic/
benthic organisms. There are few studies on the response of
invertebrates to GBMs, especially with benthic habitat. Artemia
salina exposed to GO exhibited no acute toxicity even when GO
aggregated in the intestine.280 Daphnia magna exhibited an
accumulation of graphene on the order of 1% of the body’s dry
mass after exposure to 250 μg/L of 14C-labeled graphene for
24 h; accumulated graphene in adult Daphnia was likely
transferred to neonates.281 In the cladoceran, Ceriodaphnia dubia,
a signiﬁcant decrease in the number of neonates and in feeding
rates was observed after exposure to GO.282 GO impacted the
regenerative capacity of the polychaete, Diopatra neapolitana
exposed to higher concentrations regenerating less segments and
taking longer periods to completely regenerate and altered
energy-related responses, especially glycogen content.283 In the
oligochaete,Tubifex tubifex, nomortality was observed following
GO exposure, whereas burrowing activity was signiﬁcantly
reduced.284 The toxicity of GO toward the protozoa Euglena
graciliswas evidenced by the inhibition of growth and the enhance-
ment of malondialdehyde content and antioxidant enzyme
activities.285 Some benthic species may have pelagic developmental
stages, such as the marine crustacean Amphibalanus amphitrite,
whose larvae showed mobility inhibition, as well as mortality,
after exposure to GO.286
One important factor that can inﬂuence the behavior of
nanomaterials in the environment is the presence of natural
organic material, ubiquitous in natural aquatic environments
its main components being humic substances (approximately
50%), polysaccharides, lipids, proteins, and other organic
materials.287 Castro et al. recently evaluated the eﬀect of GO
on aquatic ecosystems considering the interaction with humic
acid on nine diﬀerent organisms: Raphidocelis subcapitata (green
algae), Lemna minor (aquatic plant), Lactuca sativa (lettuce),
Daphnia magna (planktonic microcrustacea), Artemia salina
(brine shrimp), Chironomus sancticaroli (chironomidae), Hydra
attenuata (freshwater polyp), and C. elegans and Panagrolaimus
sp. (nematodes).288 Overall, GO showed low acute toxicity for
the aquatic bioindicator organisms included in the study. Inter-
estingly, the presence of humic acid in the medium increased its
colloidal stability in some cases and caused an increase in the
toxicity of GO to microcrustaceans (growth rate) and to C.
elegans (fertility and reproduction).288 The authors proposed
that the approach could be useful for predicting ecologically safe
GO concentrations and that it could also support environmental
risk assessment of GBMs.
Eﬀects of Graphene-Based Materials on Vertebrates.
The most studied vertebrates in ecotoxicology are aquatic
juvenile ﬁshes and amphibian larvae. Among ﬁshes, the zebraﬁsh
(Danio rerio) model is well-represented. As pelagic vertebrates,
they may show resistance to carbon-based nanomaterials from
the embryonic stage despite the widespread biodistribution
observed within the body.289 In embryos, GO can be integrated
into the chorion causing hypoxia and a signiﬁcant delay in hatch-
ing.290 A slight inhibition of cell growth (without signiﬁcant
induction of apoptosis) and a slight hatching delay after
exposure to GO were also observed.291 The latter study suggests
that GO is less toxic to aquatic organisms than MWCNTs as the
nanotubes yielded a strong growth inhibition at the same con-
centrations in zebraﬁsh. In adult zebraﬁsh, GO exposure caused
an increase in the number of apoptotic and necrotic gill cells, but
genotoxicity was not observed.292 Zhang et al. reported that the
development of zebraﬁsh embryos exposed to “trace concen-
trations” (1−100 μg/L) of single-layer GO was impaired
because of DNA modiﬁcation, protein carbonylation, and
excessive ROS generation.293 The authors noted skeletal and
cardiac malformations and transcriptomics analyses revealed
dysregulation of collagen and matrix metalloproteinase-related
genes following exposure to 100 μg/L of GO.
Studies conducted on amphibian larvae (Ambystoma mexica-
num) have shown that no mortality or growth inhibition nor any
genotoxicity could be observed, despite a high intake of carbon-
based nanomaterials in the digestive tract.294 In contrast, in
Xenopus laevis larvae, the highest concentration of carbon nano-
tubes resulted in an inhibition of larval growth, which would be
related to the presence of agglomerates in the digestive tract.295,296
In a recent study conducted in the Graphene Flagship, MLG
composed of 2−20 layers was found to be largely nontoxic for
Xenopus larva, with growth inhibition only at concentrations of
10 or 50 μg/mL and no signs of genotoxicity or lethality.297
Other recent studies in the Graphene Flagship have shown that
the eﬀects of FLG, nanodiamonds, carbon nanotubes, oxidized
carbon nanotubes, and GO on the growth inhibition in Xenopus
larvae are governed by surface area, whereas mass concentration
is a poor descriptor of toxicity for these diﬀerent types of carbon
allotropes298,299 (Figure 8). Notably, whatever the amphibian
organisms, intestinal absorption of carbon-based nanomaterials
seems to be limited after oral administration and the materials
are then rapidly excreted.295,296 The available data suggest that
growth inhibition observed in amphibians is related to physical
blockage of the gills and/or digestive tract, limiting the exchange
surfaces between the gills and/or gut lumen and the internal wall,
leading to a decrease in absorption of nutrients and/or gas (anoxia).
Further Research Topics in Ecotoxicology of Graphene-
Based Materials. Conventional ecotoxicological approaches
using single species are very informative and are needed to
evaluate toxicity at the organism level to understand the poten-
tial toxicity of GBMs. However, more sophisticated systems are
required to get closer to their actual environmental risk assess-
ment. In particular, the notions of biotransformation, bioaccu-
mulation, and biomagniﬁcation are generally ignored though
they are extremely relevant. Therefore, complex exposure sys-
tems with which to evaluate the impact of nanomaterials, parti-
cularly through the reconstitution of experimental trophic chains
using micro- or mesocosms as experimental tools, are gaining
traction.300−302 Such systems provide experimental conditions
closer to those found in natural ecosystems, but they allow only
limited control of biotic and abiotic parameters. These complex
systems involving interspecies interactions (e.g., predation and
competition) have been used to evaluate the eﬀect of various
nanomaterials.303,304
Furthermore, another relevant ecotoxicological aspect that is
relatively poorly investigated is the impact of “indirect”
nanotoxicity, i.e., the toxic ampliﬁcation of other toxicants or
pollutants by nanomaterials. It is fundamental to understand
how nanomaterials in general, and GBMs, in particular, interact
with other pollutants co-occurring in the environment in terms
of adsorption, transport, bioavailability, and the subsequent
eﬀects upon pollutant toxicity and biodegradability. For
instance, GO can apparently amplify phytotoxicity of arsenic
in wheat,Triticum aestivum,305 and of cadmium in the freshwater
cyanobacterium, Microcystis aeruginosa.250 The ﬁrst conclusion
is that GBMs in the environment might lead to a potential
enhancement of background contaminants toxicity, even at low
nontoxic concentrations. Themain limitation of this research ﬁeld
is the enormous number and possible combinations of substances
that might deserve to be tested. One additional aspect concerns
the assessment of degradation of GBMs released into the envi-
ronment. There are only a few studies on the capacity of primary
decomposers (i.e., bacteria and fungi) to degrade graphitic
materials, and the information available so far concerns the
eﬀects on the activity of single bacteria306 or whole soil bacteria
communities.307,308 The huge diversity and versatility of bacteria
make them the best candidates among all living organisms to
study the degradation of carbon-based nanomaterials including
GBMs. Their metabolic versatility allows them to use organic
materials dispersed in the environment as sources of reduced
carbon thanks to extracellular degradation processes.309 Further-
more, microbial communities are known to colonize contami-
nated sites and have the ability to metabolize recalcitrant organic
xenobiotics.310 White rot fungi may represent an alternative
promising ﬁeld of study because they are able to extrude digestive
or oxidative enzymes to break down lignin and other complex
organic molecules, and for this reason, they are frequently used
in remediation applications.311 Previous studies showed that
two white rot basidiomycete fungi (Phlebia tremellosa and
Trametes versicolor) could oxidize C60 fullerol to CO2.
312 How-
ever, a recent study in which Phanerochaete chrysosporium was
exposed for 14 days to GO (0−4 mg/mL) showed that GO
stimulated growth at low concentrations, whereas inhibitory
eﬀects were seen at the highest concentrations, with a complete
loss of decomposition activity due either to growth inhibition
and/or defective enzyme excretion.313 On the other hand, rGO
was reported to show low toxicity for P. chrysosporium.314 Over-
all, there are relatively few studies concerning biodegradation of
GBMs in the natural environment, and the environmental fate of
GBMs is still largely unknown. In addition, we believe that
further studies are needed to understand whether GBMs may
elicit toxicity ampliﬁcation of other environmental pollutants.
However, the data on GBMs provided by using numerous
vertebrate and nonvertebrate organisms could be used to inform
in silico toxicity models and the development of adverse outcome
pathways (AOPs). The AOP concept, ﬁrst presented as a con-
ceptual framework to support ecotoxicology research and risk
assessment,315 has attracted a great deal of attention in recent
years. The overall objective is to support regulatory decision
Figure 8. Choosing the best dose metric. Growth inhibition in Xenopus laevis larvae after a 12 day exposure to few layer graphene,
nanodiamonds, and double-walled or multiwalled carbon nanotubes. Normalized size (%) is plotted versus the base-10 logarithms of three
diﬀerent metrics: mass concentration (mg·L−1), number concentration (L−1), and surface area concentration (m2·L−1). Black dashed lines
represent nonlinear regression model predictions, and shaded areas are 95% conﬁdence intervals (CIs). The 95% CIs on the mean sizes are
represented as vertical error bars. Reprinted from ref 298. Copyright 2016 American Chemical Society.
making, such as hazard identiﬁcation and risk assessment, by
delineating the key events leading to adverse outcomes.316 AOPs
are chemically “agnostic” in the sense that they describe in a
generalized way how a molecular initiating event is linked to an
adverse outcome via so-called key events. Nonethelesss, the rich
source of hazard data emerging for GBMs could be proﬁtably
exploited in the framework of environmental risk assessment
and help in the understanding of the contribution of GBMs in
the adverse eﬀects observed in humans and wildlife at larger
organizational scale.
EXPOSURE AND LIFE CYCLE ANALYSIS OF
GRAPHENE-BASED MATERIALS
The main human exposure of concern at present is pulmonary
exposure in workers during the production and handling of GBMs,
even though dermal or oral exposuremay also occur.4Naturally, the
safety of scientists and students producing or studying nano-
materials including GBMs should not be neglected, though the
release of nanomaterials in such workplaces is likely to be very
low according to recent studies.317,318 Future biomedical appli-
cations ofGBMswill also lead to exposure in patients, but all (novel)
medicines and medical devices need to be evaluated for safety.
Occupational Exposure to Graphene-Based Materials.
Five studies related to occupational exposure of GBMs are avail-
able. The GBMs were produced by using a graphite exfolia-
tion,319,320 a chemical vapor deposition (CVD) process,166,320
and through a nonspeciﬁed technique, most likely CVD.321,322
Unfortunately, these studies did not report the GBM speciﬁ-
cations or production volumes. Thus, some results can be
applied forGBMs at laboratory scale production volumes (less than
grams)166,320 and some at industrial scale production.319,321,322
Spinazze ̀ et al. performed long-term measurements,319 whereas the
other studies were performed over one process cycle. Thus, the
variation in exposure levels is not well-known. However, all the
studies in this sample showed that exposure levels were very low
if emission controls were properly applied and good working
practices were followed. TheNational Institute forOccupational
Safety and Health in the United States published a report on
engineering controls for production and handling of GBMs (i.e.,
GNPs).321 The authors measured worker breathing zone con-
centration levels during production of GBMs using two diﬀerent
similar processes for large batches (P1) and small batches (P2).
They reported the concentrations measured during product
harvesting and process tank cleaning. Product harvesting was
made without using exposure controls at P1 or by using a blower
located downstream and butterﬂy valves incorporated on the
upstream of the collection vessels at P2. GBM release was
detected during product harvesting where a collection container
was removed from discharger and during process tank cleaning.
Good working practices and proper use of emission controls
reduced the exposure levels from 88 to >99.9%. Bengtson et al.
measured graphene exposure levels during synthesis of graphene
by a commercially available CVD system without using any
engineered emission controls.166 The measurements were carried
out in a clean room and at an industrial site over one production
cycle. In the clean room, the background level of particle number
concentration range was <5 cm−3, and the concentration
measured next to the hatch by a condensation particle counter
remained mainly at the background level. Only reactor opening
and dry wiping the reactor increased the concentration up to
around 15 cm−3 for a few seconds. Samples contained no
particles according to TEM analysis. The authors also could not
exclude that the concentration increases during opening of the
reactor and dry wiping were due to disturbance of tubing and
ﬂows to the condensation particle counter. In the industrial site,
they could not detect an increase in concentrations measured
next to the hatch due to high background particle concen-
tration.166 Lee et al. studied worker exposure during laboratory-
scale production of graphene using a graphite exfoliation and
CVD processes and transferring the graphene to a polyethylene
terephthalate (PET) sheet.320 The graphite exfoliation is made
in liquid, which is not expected to release airborne particles. The
highest release potential was expected to be during sonication,
but the process was enclosed andGBMswere not detected in the
air. During the CVD process, particle number concentration
increased for a short period during GBM collection. The transfer
of the GBMs to the PET sheets and the cutting of the sheets did
not result in any detectable increase in concentrations. GBM-
like structures were found from particle samples collected from
air of both production areas. Spinazze ̀ et al. performed six
measurement campaigns during a period of 12 months in an
industrial facility with a GBM production capacity of 30 tons per
year.319 The manufacturing process consisted of the following
steps: (1) acceptance of raw materials (graphite) and storage,
(2) plasma expansion, (3) postplasma treatment/exfoliation
performed in liquid media, (4) drying, (5) ﬁnishing operations
(e.g., packaging), and (6) storage of ﬁnal products. The process
was automated and the workers’ tasks were acquiring samples for
quality control, cleaning, and maintenance operations. The esti-
mated 8 h time-weighted average concentrations ranged from
909 to 6438 particles/cm3 and from 0.38 to 3.86 μg/m3.
Gravimetric analysis of cascade impactor samples from the
graphene expansion room showed that 65% of the mass was in
the size range of 250−500 nm. However, the authors did not
analyze the composition of the airborne particles. Nonetheless,
the study suggested, overall, that signiﬁcant exposure of workers
to GBMs is unlikely. However, the results also indicated that
workers who are directly involved in speciﬁc tasks (e.g., material
sampling for quality control) have a higher potential for occupa-
tional exposure than those involved in routine production.319
Life Cycle Analysis Approaches for Graphene-Based
Materials. Information on toxicity, biodistribution, fate, and
exposure are essential to understand the hazard of introducing
GBMs in the environment, but they can also be useful to assess
the environmental sustainability of producing and using GBMs.
The life cycle assessment (LCA)methodology provides a frame-
work for such an assessment by combining models of fabrication
processes and their associated supply chains with models of
GBM interactions in the environment.323 Here, we overview
recent LCA studies on GBMs to highlight the current state of
knowledge as well as gaps in the environmental sustainability
assessments. Thus far, LCA studies have focused on identifying
the main sources of environmental impacts for graphene,324,325
graphite nanoplatelets,326 and reduced GO.327 These studies
have addressed diﬀerent fabrication methods such as chemical
reduction, ultrasonication exfoliation, thermal exfoliation
combined with ball-milling, chemical vapor deposition, and
epitaxial growth. For instance, studies performed in the frame of
the MISTRA Environmental Nanosafety project have high-
lighted diﬀerences for graphene produced by ultrasonication or
chemical reduction in terms of energy and water use as well as
human and ecotoxicity327 (Figure 9). The results of these
studies vary signiﬁcantly because of the range of considered
GBMs, fabrication methods, and scales of production. However,
they all show that energy consumption and chemicals used (e.g.,
diethyl ether and methane) are the two most important sources
of environmental impacts for categories such as global warming
potential, freshwater ecotoxicity, human toxicity, and water use.
Although these recent LCA studies oﬀer some insights into the
environmental sustainability of GBMs, key issues remain to be
addressed. The main concern originates from the sources of data
for these studies as they are based on scientiﬁc papers, patents,
and prospective models which instigate model uncertainties that
are still diﬃcult to evaluate. Additionally, other assumptions on
the fabrication methods could be reﬁned. For example, Arvidsson
et al. used a 95−99% yield hypothesis for the ultrasonication pro-
cess of graphite into graphene,327 but such a high yield would
probably raise concerns on the purity of the fabricated graphene.
This example thus raises the issue of providing an appropriate
environmental sustainability assessment for a wide range of
GBMs as a function of their properties that can vary signiﬁcantly
and aﬀect their usefulness in diﬀerent applications. In this con-
text, the properties that should be used for classifying the diﬀer-
ent GBMs must be related to the applications of the materials.
Thus, properties such as mechanical strength, electrical conduc-
tivity, thermal conductivity, optical absorption, and surface-to-
mass ratio could all be relevant to deﬁne such groups.
The deﬁnition of such groups would allow for relevant com-
parisons with respect to the environmental impact. However,
it remains important to consider prospective scenarios for these
fabrication models as it is expected that applications of graphene
will not reach maturity before the period 2025−2030,1 and the
electricity mixes worldwidekey inputs when it comes to energy
consumptionare expected to evolve signiﬁcantly in their
composition (and thus in their related environmental impacts)
if greenhouse gas targets are to be met at the international level.
The other important concern that arises from the recent LCA
studies on GBMs is the lack of consideration for the human and
ecotoxicity of GBMs. This omission is currently explained by the
lack of GBM speciﬁc characterization factors (CFs) within the
existing life cycle impact assessment framework. Such CFs
would, in theory, translate the eﬀects of GBM emissions into
potential toxicity eﬀects on humans, animals, plants, and other
living organisms of the environment. The so-called USETox
method developed under the auspices of the UNEP/SETAC
Life Cycle Initiative328 is currently the recommended method
for providing such CFs within the LCA framework, but it
requires toxicity results from in vivo studies at diﬀerent trophic
levels and it is not speciﬁcally designed for nanomaterials. The
method also requires models for the fate and exposition to
nanomaterials. Some progress has been made in this regard by
Salieri et al.329 and Ettrup et al.330 Both groups have used and
modiﬁed the so-called Simplebox4nanomultimedia model331 and
calculated aquatic toxicity CFs for TiO2 nanoparticles. Overall,
these speciﬁc fate and exposure models could be modiﬁed to be
used for other nanomaterial such as GBMs (reviewed in ref 332).
However, only preliminary evaluations of toxicity CFs for GBMs
can be extrapolated from the available data. Therefore, it is not
expected that LCA studies will be able to oﬀer a complete
evaluation of potential impacts of GBMs until further in vivo
toxicity studies are carried out.
CONCLUDING REMARKS
With the present review, we have attempted to give an overview
of the state-of-the-art of human and environmental hazard
assessment of GBMs and to highlight the importance of under-
standing the structure−activity relationships that underlie the
potential toxicity of these materials. For this to happen, we need
to “know the materials”.333 In addition, it is equally important to
use robust and validated assays for toxicological testing with
respect to human health and environmental safety.334 Further-
more, whereas research on GBMs should address issues relevant
for risk assessment,4 studies are also needed that address the
fundamental aspects of their biological interactions.335,336
To this end, systems biology approaches provide a means with
which to dissect the mechanisms underlying the adverse eﬀects
of GBMs while yielding additional insights into the behavior of
this class of biomaterials in living systems.337
The present overview of the literature has shown that while
the hazard assessment of GBMs is coming of age, with ever
increasing numbers of studies addressing the potential impact of
GBMs on living systems, data gaps still remain, and this,
therefore, precludes the prediction of toxicity based solely on
material properties of GBMs. Indeed, we have shown that for
some selected end-points, one may begin to see a (predictable)
pattern of eﬀects (refer to supporting Figures S1−S5 and Tables
S1−S5), but it is also clear that the chemical space of graphene
and its derivatives is yet to be fully explored (Figure 1). How-
ever, it is hoped that as this framework is populated with addi-
tional studies, ideally using libraries of GBMs, or at any rate
using GBMs that have undergone rigorous characterization, the
structure−activity relationships of these materials may reveal
Figure 9. Life cycle analysis of graphene production. The chemical reduction route (CRR) and the ultrasonication route (USR) are two liquid
phase exfoliation routes with industrial-scale potential at low costs. The ﬁgure illustrates the results of the sensitivity analysis. Reprinted from
ref 218. Copyright 2016 American Chemical Society.
themselves. Indeed, it is important to move from a descriptive to
a predictive toxicology. Nel and co-workers338 proposed the use
of mechanism-based high-throughput screening to make
predictions about the physicochemical properties of nanoma-
terials that may lead to disease outcomes in living organisms.
Integral to this approach is the fact that the majority of screening
assays are carried out in vitro while critical validation assays
are performed in animals or in whole organisms, e.g., zebraﬁsh
embryos. To this, onemay add that systems toxicology approaches
also may shed light on the interactions of nanomaterials with
living organisms.339 Moreover, omics data sets (e.g., transcripto-
mics, proteomics, and metabolomics) can aid in the identiﬁ-
cation of molecular initiating events and provide supportive
evidence of key events at diﬀerent levels of biological organi-
zation, thus enriching AOPs.340 AOPs, in turn, could aid in the
development of predictive models, ultimately supporting risk
assessment of chemicals and nanomaterials341 including GBMs.
The European Commission’s Joint Research Centre (JRC)
recently published a review of the current status of computational
methods that are potentially useful for predicting the properties of
engineered nanomaterials.342 The authors identiﬁed several issues
hampering the development, uptake, and use of such models,
including methods for physicochemical and hazard character-
ization, sharing and accessibility of data, regulatory applicability of
the models, and so on. Indeed, to fully exploit (quantitative)
structure−activity relationship or (Q)SAR modeling, stronger
collaborations between experimental scientists and modelers are
required.343 Nonetheless, in silico approaches could provide a
means of extracting non-obvious structure−activity relation-
ships of GBMs provided that the test materials are well-
characterized and test systems are robust. In 2017, the European
Commission published eight NanoData Landscape Compila-
tion reports (see https://publications.europa.eu/en/). These
reports oﬀer a snapshot of the environment for nanotechnology
in diﬀerent application ﬁelds. In the report on “health”, GBMs
are hardly mentioned, whereas in the report on “environment”,
the authors have stated that “based on the scarce available
evidence, it cannot be excluded that some forms of graphene will
be as potent a toxicant as carbon nanotubes”. This statement
raises the spectre of asbestos-like properties of carbon
nanotubes,5 but according to a recent report published by the
International Agency for Research on Cancer (IARC), only
certain types of rigid, multiwalled carbon nanotubes can be
classiﬁed as being possibly carcinogenic to humans.344 More-
over, as we have discussed at length in the present review, GBMs
cannot be grouped together as one material. Indeed, GBMs
diﬀer with respect to three key parameters: the number of graph-
ene layers, average lateral dimensions, and carbon-to-oxygen
atomic ratio.22 Furthermore, GBMs can be functionalized in a
multitude of diﬀerent ways, thereby changing their properties
and, in all likelihood, their biological behavior. The fact that
GO140 and FLG345 can be digested by cells of the immune sys-
tem implies that thesematerials are not necessarily biopersistent.
Notably, research conducted in the context of the Graphene
Flagship and by other investigators in the past several years has
shown that the hazard potential for diﬀerent members of the
GBM family may vary considerably, and it is not a valid state-
ment that all GBMs are as hazardous as carbon nanotubes, nor is
it true that all carbon nanotubes are hazardous. In fact, the devil is
in the details, and careful characterization of material properties is
of critical importance. Furthermore, it is equally important that the
material properties are reported in full in papers dealing with
(eco)toxicity assessment of GBMs. Can the information that has
been collected on safety of GBMs be applied to other 2D
materials? We believe that some aspects might be common to all
2D materials, or even to all nanomaterials, while some “post-
carbon” 2D materials will likely present with their own speciﬁc
concerns. For instance, the propensity to dissolve in a biological
environment with the release of ionic species that are more
biologically/chemically reactive than the parental 2D material is
an issue that has not been described for GBMs.346 Moreover,
Guiney et al.347 recently commented that “with a constantly
expanding library of 2D materials, the ability to predict toxi-
cological outcomes is of critical importance” and suggested that
high-throughput screening approachesmay prove useful in order
to elucidate cellular interactions of 2D materials. However, the
issue is not so much the low throughput of current approaches as
much as the inconsistent design of commonly used toxicity assays
and frequent lack of material characterization. Indeed, careful
characterization of both the test material and the test system is
required, and a proposal was recently put forward for minimum
reporting requirements in publications dealing with nano-
biointeractions.348 Though such reporting requirements have
not yet been adopted, it is important to discuss these issues in
the scientiﬁc community. To conclude, the hype that inevitably
followswith technological advances should be tempered by sound,
science-based assessment of the potential impact on human health
and the environment to ensure safe and sustainable development
of new products and applications. The present survey of the
literature can perhaps serve as a ﬁrst step toward a systematic
collection of data on the safety or biocompatibility of GBMs.
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graphene-based materials, family of carbon-based materials
including graphene, graphene oxide, reduced graphene oxide,
and graphene quantum dots; life cycle assessment, technique
for examining the inputs and outputs of materials and the
associated environmental impacts directly attributable to a
product throughout its life cycle; systems biology, approach in
biomedical research to understand the complexity at organism,
tissue or cellular level, leading to a deeper comprehension of
complex biological networks and processes; nanosafety, safety
issues associated with nanotechnologies, encompassing topics
like nanomaterial characterization, eﬀects of nanomaterials on
human health and the environment, and exposure and risk
assessment; biodegradation, process by which a microorganism
transforms or alters the structure of an organic material through
metabolic or enzymatic actions; biodistribution, determination
of the location of compounds traveling within an organism
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C Is an Ideal Substitute for Hydrazine in the Reduction of Graphene
Oxide Suspensions. J. Phys. Chem. C 2010, 114, 6426−6432.
(45) Zhu, C.; Guo, S.; Fang, Y.; Dong, S. Reducing Sugar: New
Functional Molecules for the Green Synthesis of Graphene Nano-
sheets. ACS Nano 2010, 4, 2429−2437.
(46) Haghighi, B.; Tabrizi, M. A. Green-Synthesis of Reduced
Graphene Oxide Nanosheets Using Rose Water and a Survey on Their
Characteristics and Applications. RSC Adv. 2013, 3, 13365−13371.
(47) Akhavan, O.; Ghaderi, E. Escherichia Coli Bacteria Reduce
Graphene Oxide to Bactericidal Graphene in a Self-Limiting Manner.
Carbon 2012, 50, 1853−1860.
(48) Aunkor, M. T. H.; Mahbubul, I. M.; Saidur, R.; Metselaar, H. S.
C. The Green Reduction of Graphene Oxide. RSC Adv. 2016, 6,
27807−27828.
(49) Soltani, T.; Kyu Lee, B. A Benign Ultrasonic Route to Reduced
Graphene Oxide from Pristine Graphite. J. Colloid Interface Sci. 2017,
486, 337−343.
(50) Wang, Z.; Xu, D.; Huang, Y.; Wu, Z.; Wang, L.; Zhang, X. Facile,
Mild and Fast Thermal-Decomposition Reduction of Graphene Oxide
in Air and Its Application in High-Performance Lithium Batteries.
Chem. Commun. 2012, 48, 976−978.
(51) Yang, D.; Velamakanni, A.; Bozoklu, G.; Park, S.; Stoller, M.;
Piner, R. D.; Stankovich, S.; Jung, I.; Field, D. A.; Ventrice, C. A.; Ruoff,
R. S. Chemical Analysis of Graphene Oxide Films after Heat and
Chemical Treatments by X-Ray Photoelectron and Micro-Raman
Spectroscopy. Carbon 2009, 47, 145−152.
(52)Mori, F.; Kubouchi, M.; Arao, Y. Effect of Graphite Structures on
the Productivity and Quality of Few-Layer Graphene in Liquid-Phase
Exfoliation. J. Mater. Sci. 2018, 53, 12807−12815.
(53) Ding, J.-H.; Zhao, H.-R.; Yu, H.-B. A Water-Based Green
Approach to Large-Scale Production of Aqueous Compatible Graphene
Nanoplatelets. Sci. Rep. 2018, 8, 5567.
(54) Reddy, V.; Satish Babu, K. K. C.; Torati, S. R.; Eom, Y. J.; Trung,
T. Q.; Lee, N.-E.; Kim, C. Scalable Production of Water-Dispersible
Reduced Graphene Oxide and Its Integration in a Field Effect
Transistor. J. Ind. Eng. Chem. 2018, 63, 19−26.
(55) Balasubramanyan, S.; Sasidharan, S.; Poovathinthodiyil, R.;
Ramakrishnan, R. M.; Narayanan, B. N. Sucrose-Mediated Mechanical
Exfoliation of Graphite: A Green Method for the Large Scale
Production of Graphene and Its Application in Catalytic Reduction
of 4-Nitrophenol. New J. Chem. 2017, 41, 11969−11978.
(56) Gonzaĺez, V. J.; Rodríguez, A. M.; Leoń, V.; Frontiñań-Rubio, J.;
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Vaźquez, E. Sweet Graphene: Exfoliation of Graphite and Preparation
of Glucose-Graphene Cocrystals through Mechanochemical Treat-
ments. Green Chem. 2018, 20, 3581−3592.
(57) Zhang, X.; Wang, L.; Lu, Q.; Kaplan, D. L. Mass Production of
Biocompatible Graphene Using Silk Nanofibers. ACS Appl. Mater.
Interfaces 2018, 10, 22924−22931.
(58) Kim, H.-R.; Lee, S.-H.; Lee, K.-H. Scalable Production of Large
Single-Layered Graphenes by Microwave Exfoliation ‘in Deionized
Water. Carbon 2018, 134, 431−438.
(59) George, G.; Sisupal, S. B.; Tomy, T.; Kumaran, A.; Vadivelu, P.;
Suvekbala, V.; Sivaram, S.; Ragupathy, L. Facile, Environmentally
Benign and Scalable Approach to Produce Pristine Few Layers
Graphene Suitable for Preparing Biocompatible Polymer Nano-
composites. Sci. Rep. 2018, 8, 11228.
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Meńard-Moyon, C.; Kostarelos, K.; Bianco, A. Covalent Chemical
Functionalization Enhances the Biodegradation of GrapheneOxide. 2D
Mater. 2018, 5, 015020.
(139) Kurapati, R.; Russier, J.; Squillaci, M. A.; Treossi, E.; Meńard-
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Tubaro, A. Graphene and Graphene Oxide Induce ROS Production in
Human HaCaT Skin Keratinocytes: The Role of Xanthine Oxidase and
NADH Dehydrogenase. Nanoscale 2018, 10, 11820−11830.
(156) Erf, G. F.; Falcon, D. M.; Sullivan, K. S.; Bourdo, S. E. T
Lymphocytes Dominate Local Leukocyte Infiltration in Response to
Intradermal Injection of Functionalized Graphene-Based Nanomateri-
al. J. Appl. Toxicol. 2017, 37, 1317−1324.
(157) Ou, L.; Song, B.; Liang, H.; Liu, J.; Feng, X.; Deng, B.; Sun, T.;
Shao, L. Toxicity of Graphene-Family Nanoparticles: AGeneral Review
of the Origins and Mechanisms. Part. Part. Fibre Toxicol. 2016, 13, 57.
(158) Roberts, J. R.; Mercer, R. R.; Stefaniak, A. B.; Seehra, M. S.;
Geddam, U. K.; Chaudhuri, I. S.; Kyrlidis, A.; Kodali, V. K.; Sager, T.;
Kenyon, A.; Bilgesu, S. A.; Eye, T.; Scabilloni, J. F.; Leonard, S. S.; Fix,
N. R.; Schwegler-Berry, D.; Farris, B. Y.; Wolfarth, M. G.; Porter, D.W.;
Castranova, V.; et al. Evaluation of Pulmonary and Systemic Toxicity
Following Lung Exposure to Graphite Nanoplates: A Member of the
Graphene-Based Nanomaterial Family. Part. Part. Fibre Toxicol. 2015,
13, 34.
(159) Schinwald, A.; Murphy, F. A.; Jones, A.; MacNee, W.;
Donaldson, K. Graphene-Based Nanoplatelets: A New Risk to the
Respiratory System as a Consequence of Their Unusual Aerodynamic
Properties. ACS Nano 2012, 6, 736−746.
(160) Schinwald, A.; Murphy, F.; Askounis, A.; Koutsos, V.; Sefiane,
K.; Donaldson, K.; Campbell, C. J. Minimal Oxidation and
Inflammogenicity of Pristine Graphene with Residence in the Lung.
Nanotoxicology 2014, 8, 824−832.
(161) Park, E.-J.; Lee, G.-H.; Han, B. S.; Lee, B.-S.; Lee, S.; Cho, M.-
H.; Kim, J.-H.; Kim, D.-W. Toxic Response of Graphene Nanoplatelets
in Vivo and in Vitro. Arch. Toxicol. 2015, 89, 1557−1568.
(162) Park, E.-J.; Lee, S. J.; Lee, K.; Choi, Y. C.; Lee, B.-S.; Lee, G.-H.;
Kim, D.-W. Pulmonary Persistence of Graphene Nanoplatelets May
Disturb Physiological and Immunological Homeostasis. J. Appl. Toxicol.
2017, 37, 296−309.
(163) Shin, J. H.; Han, S. G.; Kim, J. K.; Kim, B.W.; Hwang, J. H.; Lee,
J. S.; Lee, J. H.; Baek, J. E.; Kim, T. G.; Kim, K. S.; Lee, H. S.; Song, N.
W.; Ahn, K.; Yu, I. J. 5-Day Repeated Inhalation and 28-Day Post-
Exposure Study of Graphene. Nanotoxicology 2015, 9, 1023−1031.
(164) Kim, J. K.; Shin, J. H.; Lee, J. S.; Hwang, J. H.; Lee, J. H.; Baek, J.
E.; Kim, T. G.; Kim, B. W.; Kim, J. S.; Lee, G. H.; Ahn, K.; Han, S. G.;
Bello, D.; Yu, I. J. 28-Day Inhalation Toxicity of Graphene
Nanoplatelets in Sprague-Dawley Rats. Nanotoxicology 2016, 10,
891−901.
(165) Lee, J. K.; Jeong, A. Y.; Bae, J.; Seok, J. H.; Yang, J.-Y.; Roh, H. S.;
Jeong, J.; Han, Y.; Jeong, J.; Cho, W.-S. The Role of Surface
Functionalization on the Pulmonary Inflammogenicity and Trans-
location into Mediastinal Lymph Nodes of Graphene Nanoplatelets in
Rats. Arch. Toxicol. 2017, 91, 667−676.
(166) Bengtson, S.; Knudsen, K. B.; Kyjovska, Z. O.; Berthing, T.;
Skaug, V.; Levin, M.; Koponen, I. K.; Shivayogimath, A.; Booth, T. J.;
Alonso, B.; Pesquera, A.; Zurutuza, A.; Thomsen, B. L.; Troelsen, J. T.;
Jacobsen, N. R.; Vogel, U. Differences in Inflammation and Acute Phase
Response but Similar Genotoxicity in Mice Following Pulmonary
Exposure to Graphene Oxide and Reduced Graphene Oxide. PLoS One
2017, 12, e0178355.
(167) Bengtson, S.; Kling, K.; Madsen, A. M.; Noergaard, A. W.;
Jacobsen, N. R.; Clausen, P. A.; Alonso, B.; Pesquera, A.; Zurutuza, A.;
Ramos, R.; Okuno, H.; Dijon, J.; Wallin, H.; Vogel, U. No Cytotoxicity
or Genotoxicity of Graphene and Graphene Oxide in Murine Lung
Epithelial FE1 Cells in Vitro. Environ. Mol. Mutagen. 2016, 57, 469−
482.
(168) Poulsen, S. S.; Jackson, P.; Kling, K.; Knudsen, K. B.; Skaug, V.;
Kyjovska, Z. O.; Thomsen, B. L.; Clausen, P. A.; Atluri, R.; Berthing, T.;
Bengtson, S.; Wolff, H.; Jensen, K. A.; Wallin, H.; Vogel, U. Multi-
Walled Carbon Nanotube Physicochemical Properties Predict
Pulmonary Inflammation and Genotoxicity. Nanotoxicology 2016, 10,
1263−1275.
(169) Poulsen, S. S.; Saber, A. T.; Williams, A.; Andersen, O.; Købler,
C.; Atluri, R.; Pozzebon, M. E.; Mucelli, S. P.; Simion, M.; Rickerby, D.;
Mortensen, A.; Jackson, P.; Kyjovska, Z. O.; Mølhave, K.; Jacobsen, N.
R.; Jensen, K. A.; Yauk, C. L.; Wallin, H.; Halappanavar, S.; Vogel, U.
MWCNTs of Different Physicochemical Properties Cause Similar
Inflammatory Responses, but Differences in Transcriptional and
Histological Markers of Fibrosis in Mouse Lungs. Toxicol. Appl.
Pharmacol. 2015, 284, 16−32.
(170) Vranic, S.; Rodrigues, A. F.; Buggio, M.; Newman, L.; White, M.
R. H.; Spiller, D. G.; Bussy, C.; Kostarelos, K. Live Imaging of Label-
Free Graphene Oxide Reveals Critical Factors Causing Oxidative-
Stress-Mediated Cellular Responses. ACS Nano 2018, 12, 1373−1389.
(171) Drasler, B.; Kucki, M.; Delhaes, F.; Buerki-Thurnherr, T.;
Vanhecke, D.; Korejwo, D.; Chortarea, S.; Barosova, H.; Hirsch, C.;
Petri-Fink, A.; Rothen-Rutishauser, B.; Wick, P. Single Exposure to
Aerosolized Graphene Oxide and Graphene Nanoplatelets Did Not
Initiate an Acute Biological Response in a 3D Human Lung Model.
Carbon 2018, 137, 125−135.
(172) Shurin, M. R.; Yanamala, N.; Kisin, E. R.; Tkach, A. V.; Shurin,
G. V.; Murray, A. R.; Leonard, H. D.; Reynolds, J. S.; Gutkin, D. W.;
Star, A.; Fadeel, B.; Savolainen, K.; Kagan, V. E.; Shvedova, A. A.
Graphene Oxide Attenuates Th2-Type Immune Responses, but
Augments Airway Remodeling and Hyperresponsiveness in a Murine
Model of Asthma. ACS Nano 2014, 8, 5585−5599.
(173) Lee, B.-J.; Kim, B.; Lee, K. Air Pollution Exposure and
Cardiovascular Disease. Toxicol. Res. 2014, 30, 71−75.
(174) Du, Y.; Xu, X.; Chu,M.; Guo, Y.; Wang, J. Air ParticulateMatter
and Cardiovascular Disease: The Epidemiological, Biomedical and
Clinical Evidence. J. Thorac. Dis. 2016, 8, E8−E19.
(175)Donaldson, K.; Duffin, R.; Langrish, J. P.;Miller, M. R.;Mills, N.
L.; Poland, C. A.; Raftis, J.; Shah, A.; Shaw, C. A.; Newby, D. E.
Nanoparticles and the Cardiovascular System: A Critical Review.
Nanomedicine 2013, 8, 403−423.
(176) Contreras-Torres, F. F.; Rodríguez-Galvań, A.; Guerrero-
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